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Summary 
This work focuses on the isolation of fetal cells from the blood of pregnant women, with 
the aim of developing safe, efficacious, non-invasive alternatives for prenatal diagnosis. 
Although the fetal cells were first detected in maternal blood in the 1893, an effective 
protocol for non-invasive analysis is still not firmly established. This is due, on the one 
hand, to the scarcity of fetal cells in maternal blood, which is of the order of 1 fetal cell to 
106 - 107 maternal nucleated cells and on the other hand, to the fact that fetal cells have no 
specific cell markers.  
Efforts were made to improve development and evaluation of new fetal cell enrichment 
procedures. One of the tasks of this study was to evaluate galactose specific enrichment 
via soybean agglutinin, a galactose-specific lectin for isolation of erythroblast from 
maternal blood, and to compare this new technique with the conventional CD71 
enrichment technique.  
Another technical obstacle which had to be overcome was how to analyze the 
chromosomal content of few fetal cells enriched from the maternal circulation. Since 
these fetal erythroblasts were not actively dividing it was impossible to use standard 
cytogenetic methods. To address this issue multicolor fluorescence in situ hybridisation 
(FISH), or single cell polymerase chain reaction (PCR) procedures for analysis of fetal 
cells were developed and optimized. In the largest series of articles published to date, the 
efficacy of detecting fetal cells by the use of FISH for X and Y chromosomes was below 
what was needed. We tried to optimize the FISH procedure by applying different 
treatments to the nucleus and using different kinds of fluorescent probes firstly on cord 
blood erythroblasts as a model system. Then, after optimization, the best FISH protocols 
were applied to electronically marked erythroblasts from maternal blood. The analysis of 
FISH signals in maternal blood revealed that about half of erythroblasts did not hybridize. 
Additionally, we checked whether the ability to successfully perform FISH depended on 
chromosome choice. FISH analysis for chromosome 18 gave the same result. Thereafter 
we searched for possible reasons of FISH signal absence. The morphometric analysis of 
erythroblasts indicated that erythroblasts which had hybridized efficiently were of larger 
nuclear size than those which had been impervious to the FISH procedure; that is, the 
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efficiency of FISH procedure is connected with nuclear size. We then compared the 
erythroblasts from maternal blood with those from cord blood. The morphometric 
analysis indicated a significant difference in size between erythroblasts circulating in 
maternal blood and cord blood. 
Additionally, we wanted to determine whether the presence of fragmented DNA hindered 
the FISH analysis. The results of Terminal deoxynucleotidyl Transferase Biotin-dUTP 
Nick End Labeling (TUNEL) analysis suggested that effective FISH analysis had been 
hindered by the presence of dense nuclei rather than nuclei containing fragmented DNA. 
A point of interest was for us to look for possible reasons for nucleus size reduction of 
erythroblasts in the maternal circulation. We hypothesized that the changes in the nuclear 
size of erythroblasts could be attributed to the different oxygen tensions in the fetal and 
maternal circulatory systems. We checked and confirmed this hypothesis on model 
systems such as culture at low and normal oxygen conditions. 
Another interesting issue for us was to look in detail at the chromatin and cytoplasm 
organization of erythroblasts on a spectral level, using spectral imaging analysis, and then 
to compare the results for erythroblasts from maternal and cord blood. This analysis also 
confirmed differences between erythroblasts from maternal and cord blood. 
Which fetal target cell is best suited for analysis remains an open question. Our task was 
to evaluate the ability to perform FISH analysis of fetal cells in whole blood without any 
enrichment. One further task was to improve fetal cell recovery by applying XYY FISH 
as alternative to conventional XY FISH  
As reported by many researchers, single cell PCR analysis of fetal erythroblasts is more 
effective than FISH analysis. We checked the fetal status of small dense erythroblasts 
which appeared to be refractory to FISH analysis by Taqman PCR after laser 
microdissection capture (pool). Furthermore, we explored the opportunity of single cell 
Taqman analysis of erythroblasts enriched by soybean lectin-based (SBA) method and 
microdissected by laser microdissection and pressure catapulting (LMPC) technology 
from membrane covered slides.  
All the above–listed questions comprised the subject matter for our investigation. In what 
follows, we give a detailed description of the studies performed. 
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Aim 
Main purpose of this study is to development of non-invasive analysis of fetal cells from 
maternal blood for prenatal diagnosis. 
 
In particular, the purposes of our study are: 
 
1) To evaluate galactose-specific enrichment via soybean agglutinin for isolation of 
erythroblasts from maternal blood and to compare it with conventional CD71 
enrichment; 
2) To optimize FISH on cord blood by comparing different types of probes and 
different protocols; 
3) To apply the FISH protocols after optimization on maternal blood; 
4) To check whether the efficacy of FISH depend on chromosome choice (18 
chromosome FISH); 
5) To compare the morphometrical measurements of erythroblasts, accordingly the 
FISH signals, from maternal blood and cord blood; 
6) To check apoptosis status of erythroblasts in maternal blood and cord blood, 
applying TUNEL; 
7) To check the effect of oxygen concentration on the number of erythroblasts and 
their morphometric properties at culture at low and normal oxygen conditions; 
8) To evaluate and to compare the ability to perform XY-FISH, YY-FISH and XYY-
FISH analysis of fetal cells in whole blood; 
9) To analyze and compare the chromatin and cytoplasm organization of 
erythroblasts from maternal and cord blood on a spectral level; 
10) To check the fetal status of erythroblasts without any FISH signals by Taqman-
PCR after laser microdissection capture (pool); 
11) To optimize the single cell RT-PCR after soybean lectin-based enrichment 
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1. Introduction 
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1.1. Disadvantages of diagnosis by invasive testing and blood screening 
Currently, prenatal diagnosis of fetal genetic traits relies on invasive procedures such as 
amniocentesis, chorionic villus sampling (CVS) or fetal blood sampling. However, all 
these approaches are connected with increased risk of fetal loss or maternal injury and 
face the problems of reliability and accuracy of the results. 
Amniocentesis is time consuming and faces problems of culture failure and culture 
artefact. Culture failure can occur in up to 1% of amniotic fluid samples and 
chromosomal mosaicism in 0.5% (Hsu and Perlis, 1984). Serious maternal complications 
such as lower abdominal cramps, vaginal blood loss and amniotic fluid leakage occur in 
up to 3% of women. Occasionally, significant loss of amniotic fluid may be associated 
with neonatal complications (Finegan et al., 1990). In the large randomised controlled 
trial, done in 4,606 low-risk healthy women between 25-34 years, it was shown that the 
excess risk of miscarriage due to amniocentesis was as high as 1% (Tabor et al., 1986). 
The problem with Chorion Villus Sampling (CVS) is that the discrepancies exist 
between the cytogenetic results of culture and the actual fetal karyotype. One reason for 
this is that placental mosaicism due to the structure of chorionic villi (Slunga-Tallberg 
and Knuutila, 1995). The incidence of confined placental mosaicism in CVS specimens is 
1.5% (Hahnemann and Vejerslev, 1997). Another reason for the discrepancies is 
phenomenon called trisomy rescue (Ledbetter and Engel, 1995). Natural selection against 
aneuploidy often leads to loss of the supernumerary chromosome in an originally trisomic 
embryo. In addition, it is accepted that CVS is a slightly more risky procedure than 
amniocentesis, with a procedure-related miscarriage rate around 2% (Rhoads et al., MRC 
Working Party, 1991).  
The Fetal Blood Sampling procedure is associated with a risk of miscarriage of about 2% 
(Buscaglia et al., 1996). The main causes of fetal loss are rupture of membranes, 
chorioamniotis, and puncture of the umbilical artery, bleeding from the puncture site and 
prolonged bradycardia. The frequency of procedure-related losses can be reduced by 
methods such as serum screening, which identify women with an increased risk of 
bearing abnormal fetuses. However, serum screening is a statistical method that identifies 
only 60-70% of fetuses with Down syndrome (with a 5% false positive rate) (Phillips et 
al., 1992). 
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Main disadvantage of all those tests is that they cannot be used to provide cells for 
chromosomal analysis. Because of the uncertainties of screening and the procedure–
related risks of invasive diagnosis methods, there is considerable interest in developing 
alternatives risk free non-invasive test for prenatal diagnostic. 
 
1.2. Alternative non-invasive diagnosis 
In quest for the development of non-invasive methods for prenatal diagnosis two 
strategies have emerged; the enrichment of rare circulatory fetal cells from maternal 
blood and the analysis of cell free fetal DNA in maternal plasma. 
1.2.1. History of recovery of fetal cells and cell-free DNA in maternal circulation 
In 1893, Schmorl first have described the appearance of fetal trophoblasts in the maternal 
pulmonary vasculature (Schmorl, 1893). Then, Douglas et al. (1959) have identified 
circulating trophoblasts in maternal blood. The definitive proof that fetal cells circulate in 
maternal blood only came when lymphocytes bearing the Y-chromosome were detected 
in the peripheral blood of mother carrying male foetuses (Walknowska et al., 1969). 
Herzenberg et al. (1979) first have isolated the fetal cells using fluorescence-activated 
cell sorting (FACS). Bianchi et al. (1990) have identified the fetal erythroblast cells by Y 
chromosome sequences in male pregnancies after FACS-enrichment. Many researchers 
have demonstrated the opportunity of identification fetal aneuploidies by applying 
fluorescence in situ hybridisation (FISH) after FACS-enrichment (Price et al., 1991; 
Bianchi et al., 1992; Elias et al., 1992b; Simpson and Elias, 1993). The similar results 
were obtained after magnetic-activated cell sorting (MACS) of the fetal erythroblasts 
(Ganshirt-Ahlert et al., 1992). 
Convincing evidence of the existence of fetal DNA in maternal blood came in 1990 with 
the application of sensitive molecular technique such as polymerase chain reaction 
(PCR). Lo et al. (1989) have demonstrated by PCR the existence of fetal cell-free DNA 
in maternal plasma, which was detected in relatively much more quantity than intact fetal 
cells. Although the PCR method has rapidly established itself as the method of choice for 
the analysis of more facile fetal genetic loci, such as the presence of the Y chromosome 
in pregnancies at risk for an X-linked disorder or the fetal RhD gene in pregnancies with 
a Rhesus constellation, it is currently not possible to examine for more complex fetal 
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genetic disorders such as chromosomal anomalies by this approach. On the contrary, the 
analysis of intact fetal cells would allow a wider range of diagnoses to be made, including 
the detection the fetal aneuploidy. 
Unfortunately, the fetal cells are present relatively rarely in maternal blood, they have not 
specific fetal cell markers, that makes difficult (but not impossible) to isolate and 
physically identify them. Currently, the research in fetal cell area focuses on aims how to 
isolate and use these ones for non-invasive prenatal diagnosis. Also it is of interest to 
know their biological role and effect in the mother.  
 
1.2.2. Variety of fetal cells in the maternal circulation 
Trophoblasts are epithelial cells, which shed in the maternal blood as early as sixth week 
of gestation (Ganshirt et al., 1995); (van Wijk et al., 1996), but unlike lymphoid and 
myeloid fetal cells, they do not persist for years after delivery (Bianchi, 1999). 
Trophoblast cells are unique and of critical importance for development and functioning 
of the placenta. The trophoblasts form cytoblasts layer and multinucleate trophoblastic 
syncytium of placental villi. In addition, a certain population of cytotrophoblas invades 
the walls of uterus and its spiral arteries. It is a long known fact that syncytiotrophoblasts 
find their way into maternal circulation and are at least partly trapped in the capillaries of 
the lungs, but the extent of cytotrophoblasts invasion is still unclear. 
The trophoblasts express the cytokeratins (Zvaifler et al., 2000) and they have relatively 
large size that permits definitive microscopic identification. The use of trophoblast cells 
for non-invasive prenatal diagnosis however has met with several difficulties. 
Trophoblast deportation into the maternal circulation does not appear to be a 
phenomenon common to all pregnancies (Sargent et al., 1994). These cells are invariably 
trapped in the lungs and rapidly cleared by the pulmonary circulation (ATTWOOD and 
PARK, 1961). Furthermore, they are originating from the placenta, which is known from 
chorionic villus sampling studies to have 1% incidence of chromosomal mosaicism 
(Henderson et al., 1996), which severely restricts the use of trophoblasts for accurate 
genetic diagnosis. The enrichment for these cells has often been hindered by the lack of 
specific antibodies (Covone et al., 1984; Covone et al., 1988; Bertero et al., 1988). 
However, some groups have successfully isolated the trophoblasts from maternal blood 
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by using the specific monoclonal antibodies against trophoblast cell surface antigens 
(Mueller et al., 1990) or by “isolation by size of epithelial tumor cells” (ISET) (Vona et 
al., 2002; Beroud et al., 2003).  
One of the earlier attractions of fetal leukocytes was their ability to proliferate in vivo. 
Walknowska et al. (1969) demonstrated the presence of the Y chromosome in mitogen-
stimulated leukocytes obtained from pregnant women who were carrying male fetus. 
Now this propensity is regarded as a disadvantage, since leukocytes can proliferate in 
vivo in maternal organs and persist in the maternal blood (Schroder, 1974; Ciaranfi et al., 
1977). Thus, the case in point is that enriched leukocytes may be the vestiges of previous 
pregnancies and they do not represent fetal genetic status in the current pregnancy. 
Further limitation of using fetal leucocytes for non-invasive diagnosis is the lack of 
monoclonal antibodies specific to fetal leukocyte antigens. However, Herzenberg et al. 
(1979) have recovered fetal leukocytes from maternal blood by FACS with antibodies 
against paternally-derived HLA-A2 antigens. The fetal gender and HLA type were 
successfully predicted also by Iverson et al. (1981). 
However, none of the resulting metaphases contained a fetal karyotype when the 
separated leukocytes were grown in tissue culture in another study (Tharapel et al., 1993). 
Zilliacus et al. (1975) and Wessman et al. (1992) have raised the possibility of using fetal 
granulocytes as targets for non-invasive prenatal diagnosis, and suggested that fetal 
granulocytes are transferred into the maternal compartment from as early as seven weeks 
and on a regular basis. The fetal granulocytes comprised on average 0.13% and 
occasionally as much as 0.26%, of all mononuclear cells in maternal blood. Available 
data do not support the use of granulocytes as suitable targets. 
Relatively recently, Campagnoli et al. (2001) identified a novel population of 
mesenchymal stem cells (MSC). These cells are present in fetal blood from 7 to 14 weeks 
of gestation where they account for 0.4% of fetal nucleated cells. The frequency of these 
cells declines with gestational age. Their immunophenotype is non-haemopoietic (CD45 
negative, CD14 negative), non-endothelial (CD31 negative, CD34 negative, no 
expression of von Willebrand factor) and myofibroblastic. Circulating fetal MSC express 
a number of adhesion molecules (e.g. Vimentin, Fibronectin, VCAM-1), are HLA-DR 
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negative, and are positive for the mesenchymal markers, SH2, SH3 and SH4 (Macek et 
al., 2002). 
The multilineage potential of MSCs can be demonstrated under appropriate culture 
conditions by their differentiation into osteocytes, adipocytes, neurons, muscle cells and 
chondrocytes, but they assume fibroblastic appearance and growth pattern when cultured 
in 10% fetal calf serum. Furthermore, these cells synthesise collagen when placed in 
culture. MSC are not known to be normally present in adult or maternal blood, they are 
currently only one cell type to be present in fetal blood and not in maternal blood. 
Although the presence and quantity of MSCs in maternal circulation remain to be 
elucidated (Zvaifler et al., 2000) and still no well-defined protocol for isolation of fetal 
MSC from maternal blood exist, the ease by which these cells can be propagated in 
culture suggests they are another possible target cell for non-invasive prenatal testing 
(Uitto et al., 2003). 
Haematopoietic progenitor cells are present in the first trimester fetal blood and account 
for 5% of the total CD45 positive cell population. They can be enriched based on the 
expression of the CD34 antigen and expanded in vitro (Campagnoli et al., 2000). Despite 
culture conditions favouring fetal cells, only limited expansion of these cells over 
maternal cells in vitro has been achieved, and with few exceptions, fetal haematopoietic 
progenitors have not been successfully identified in the maternal circulation before 16 
weeks of gestation (Jansen et al., 2000). 
Thus, the cell type chosen for non-invasive prenatal diagnosis should be short lived 
within the mother, have no or only limited capacity to proliferate, and have unique cell 
surface markers to facilitate enrichment. These requirements led to the choice of the 
erythroblasts as target cell. 
The erythroblasts (Nucleated red blood cells (NRBCs) are very abundant in the early 
fetal circulation, virtually absent in normal adult blood and by having a short finite life-
span, there is no risk of obtaining fetal cells which may persist from a previous 
pregnancy. In contrast to the leukocyte, they have many cell surface markers (the 
transferrin receptor and the glycophorin A cell surface molecule) and cytoplasmic 
markers (embryonic (ζ- and ε-) or fetal (γ-) hemoglobin) that can help them to 
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differentiate. Furthermore, unlike trophoblast cells, fetal erythroblasts are not prone to 
mosaic characteristics. 
Initially, all researchers believed that all erythroblasts isolated from a maternal sample 
were fetal in origin. Later on, the newer and more sensitive techniques of enrichment used 
to detect fetal cells have allowed discovering previously under-appreciated population of 
maternal erythroblasts that circulate during pregnancy (Slunga-Tallberg et al., 1995; 
Slunga-Tallberg et al., 1996). Thus, if fetal erythroblasts are to be used as target cells for 
accurate non-invasive prenatal diagnosis, a more specific identification system needs to be 
developed. 
17 
1.3. Non-invasive prenatal diagnosis using fetal erythroblasts in 
maternal blood: current state of the art 
 
1.3.1. Number of fetal cells in maternal blood at normal and aneuploid pregnancies 
The presence of fetal cells in maternal blood is a rare event - only one fetal cell per 105-109 
of maternal cells (Ganshirt-Ahlert et al., 1990; Price et al., 1991). Takabayashi et al. (1995) 
reported on average of 2 fetal cells in 1 ml of maternal blood. Bianchi et al. (1997) 
evidenced by applying quantitative PCR, that the average number of fetal cells that can be 
isolated from maternal blood is 1.6 cells per ml when the fetal karyotype is normal. Fetal 
cell number estimation based on PCR on whole blood includes all fetal cell types, whilst 
most studies are restricted to fetal erythroblasts but nevertheless they confirm the 
observation of Bianchi et al. (1997). 
Simpson and Elias (1993) and Ganshirt-Ahlert et al. (1993) have described that the number 
of fetal cells in maternal blood increases in aneuploid pregnancies. Increased numbers of 
fetal cells in maternal blood in aneuploid pregnancies could be due to several mechanisms. 
Firstly, the placental feto-maternal barrier could be impaired due to disturbed development 
or function of placental villi, leading to an increased feto-maternal transfusion (Genest et 
al., 1995; van Lijnschoten et al., 1993). Secondly, in the trisomic fetus itself, more fetal 
cells could be present. Genest et al. (1995) have described a lack of nucleated red blood 
cells in trisomic spontaneous abortions compared with eusomic ones. This could indicate 
altered haemotopoiesis in early trisomic embryo (Thilaganathan et al., 1995), leading to an 
increased erythroblasts content in feto-maternal transfusion. Thirdly, the number of 
trisomic erythroblasts in maternal blood could be higher because these ones have a longer 
survival. 
The fact that the number of fetal cells increases at aneuploid pregnancies probably may 
contribute to diagnosing the numerical chromosomal anomalies. 
 
1.3.2. Enrichment of fetal erythroblasts from maternal blood 
Since the erythroblasts are very rare in maternal venous blood (Oosterwijk et al., 1998a; 
Pertl and Bianchi, 1999; Ganshirt-Ahlert et al., 1990), various enrichment methods exist to 
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overcome this limitation: discontinuous density gradients, magnetic activated cell sorting 
(MACS), fluorescence activated cell sorting (FACS) and lectin-based enrichment. 
1.3.2.1. Discontinuous density gradient centrifugation 
The trend to use density gradient centrifugation as the first enrichment step to 
eliminate/reduce the abundance of maternal red blood cells followed a publication by Bhat 
et al. (1993). They demonstrated, using cord blood samples, that if Histopaque-1077 was 
used alone, 82.6% of erythroblasts would pellet. Nowadays, most groups use continuous 
Ficoll gradients of different specific densities varying from 1077 to 1119. Troeger et al. 
(1999a) have found in comparative study on artificial mixture of cord and adult blood that 
the most erythroblasts was recovered when Ficoll 1119 was used as compared with lower 
density gradients 1077, 1098, 1110. Bhat et al. (1993) also have shown that if a 
discontinuous double density gradient of Histopaque-1077 and 1119 was used, less than 
0.5% of erythroblasts would collect at the top interface but 78.6% would settle at 1119.  
In 1993 Bhat et al. were again the first to report the use of triple density-gradient 
centrifugation; they have demonstrated a 25-fold enrichment of fetal nucleated red blood 
cells (Bhat et al., 1993). 
In comparative study, Al Mufti et al. (2004) have demonstrated that triple density-gradient 
separation is more effective with regard to fetal cell yield than single density gradient 
separation on maternal blood samples.  
Since then, density gradient centrifugation has been used either alone or as the first step in 
most enrichment protocols (Cheung et al., 1996; Oosterwijk et al., 1998b). 
1.3.2.2. Surface antigens 
Erythroblasts express on their surface several antigens: the transferin receptor (CD71), 
thrombospondin receptor (CD36), blood type antigens (ABO, rhesus, MN, li, etc.), 
erythropoietin receptor (Valerio et al., 1996), the fetal liver surface antigens HAE9, FB3-2 
or H3-3 (Savion et al., 1997; Zheng et al., 1997) and possibly HLA-G (Steele et al., 1996). 
Potentially-useful surface antigens for positive selection of erythroblasts are glycophorin A 
(GPA) expressed on cells of erythroid differentiation; transferin receptor (CD71) expressed 
on all proliferating cells of both red and white cell lines and the thrombospondin receptor 
(CD36), being expressed on monocytes, platelets and erythroid cells (Table 1; Figure 1). 
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The surface antigens present on the surface of other blood cells can be used for negative 
selection, for example: CD35 is present on white blood cells; CD47 is present on 
erythrocytes, and many others. 
Fetal erythroblasts were first isolated from the peripheral blood of pregnant women using 
anti-CD71 (Bianchi et al., 1990). The transferin receptor, present on all cells that 
incorporate iron including activated lymphocytes and trophoblasts, is known to be 
expressed on erythroid cells from BFU-e to the reticulocyte stage (Loken et al., 1987). 
Zheng et al. (1997) have found that 89.6% of erythroblasts from multiple or structurally 
abnormal pregnancy in the first trimester fetal blood were CD71-positive.  
Most groups have used CD71 to enrich the fetal cells based upon these findings (Cheung et 
al., 1996; Durrant et al., 1996; Zhong et al., 2000; Al Mufti et al., 2001). However, the 
disadvantages of CD71-enrichment are poor yield, which has been attributed to low 
number of target cells within maternal blood, and the lack of purity due to the fact that 
other cell types also express CD71. 
Bianchi et al. (1993) have demonstrated that GPA alone or in combination with CD71 or 
CD36 improves the retrieval of fetal NRBC from maternal blood. Troeger et al. (1999a) 
have found the using of CD36 in MACS-based protocol to be less effective than GPA or 
CD71. Two other antigens that could achieve the same objective using negative selection 
are CD35 and CD47. CD35 (complement receptor type 1 (CR1)) is present on white blood 
cells and to a lesser degree on mature erythrocytes. CD47 (integrin-associated protein) has 
recently been identified as a marker of `self` on erythrocytes (Oldenborg et al., 2000). 
A major drawback of the above antibodies is that they do not distinguish between fetal and 
maternal erythroid cells, whereas most of the erythroblasts in maternal blood are of 
maternal origin (Slunga-Tallberg and Knuutila, 1995; Holzgreve et al., 1998). 
The disadvantages of all antibody enrichments are poor yield, which has been attributed to 
low number of target cells within maternal blood, and the lack of purity of target cells in 
positive population.  
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Type of cell Antibody 
erythrocytes CD 35, CD 44, CD 55, CD 59, CD 147 
CFU-E CD 36, CDw 123, CDw 131 
BFU-E CD 33, CD 34, CDw 123, CDw 131 
myeloid 
stem cell 
CD 33, CD 34, CD 117, CDw 123, 
CDw 131 
pluripotent 
stem cell 
CD 90, CD 123, CD 117, CD 135 
lymphoid 
stem cell 
 CD 34, CD 10, CD 38, CD 90, CD 
117, CD 124, CD 127 
granulocyte
s 
CD 11b, CD 11c, CDw 12, CD 13, CD 
31, CD 43, CD 45RO, CD 52, CD 66b, 
CD 66c, CD 87, CD 88, CD 114, CDw 
101, CD 123 
 
 
Table 1. Surface antigens. 
Stem
cell
BFU-E CFU-E Erythroblast Erythrocyte
CD 34
CD 71
CD 34
CD 71
CD 36
CD 71
CD 34
CD 71
GPA
HbF
HAE 9
GPA
 
Figure 1. Surface antigens 
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1.3.2.3. Devices for antibody labeled cell sorting 
Fluorescence-activated cell sorting (FACS) and magnetic activated cell sorting (MACS) 
are the two most commonly used systems for antibody labeled cell sorting.  
FACS: Herzenberg et al. (1979) were the first who have used the FACS. The advantages 
of this technique are its ability to enrich cells with high purity, to perform multiparameter 
sorting i.e. simultaneously analyzing several criteria on a single cell; and to be adapted for 
use with intracytoplasmic antigens. Its disadvantages are its cost, expensive maintenance, 
requirement for specially–trained laboratory personnel, limitation in the number of cells 
that can be put through the system in a reasonable amount of time, fading of the 
fluorochrome if exposed to FISH after sorting and cell loss (Wang et al., 2000). 
MACS: The use of MACS for non-invasive prenatal diagnosis was first suggested by 
Ganshirt-Ahler et al. (1992). It is a faster, less expensive, bench-top technique better suited 
to process large cell numbers and can be performed in most laboratories without the need 
to trained staff and high maintenance costs. Its major disadvantage is that the cell selection 
can be based upon only a single criterion. Negative and positive selection can be 
performed on the same population of cells within the same experiment but the enrichments 
need to be carried out one at a time. Its disadvantages are: the yield and purity poorer as 
compared with FACS, slides had more maternal cell contamination (Wang et al., 2000). 
However, the absolute numbers of fetal cells recovered are comparable. 
 
1.3.2.4. RosetteSep enrichment 
Bischoff et al. (2003) have reported on improved isolation using a simple whole blood 
progenitor cell enrichment approach (RosetteSep). They enriched the NRBCs by removing 
unwanted mature T-cells, B-cells, granulocytes, natural killer cells, neutrophils and 
myelomonocytic cells using CD2, CD3, CD14, CD16, CD19, CD24, CD56 and CD66 
RosetteSep progenitor antibody cocktail (StemCell Technologies, Canada). The detection 
(FISH) rate in this pilot study was 53%, which suggests great promise. 
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1.3.2.5. Soybean Lectin-based enrichment 
Kitagawa et al. (2002) have offered the new enrichment of erythroblasts from maternal 
blood using the adsorption of erythroblasts to slides containing galactose sites by 
galactose-bearing conjugation via soybean agglutinin (SBA), a galactose-specific lectin. 
Blood cells express saccharides on their surface, which play an important role in the 
control of cellular behavior and fate (Raedler et al., 1981). Cell-surface galactose 
associated with the development and maturation of the erythrocytes is highly expressed on 
the erythroid precursor cells (Skutelsky and Bayer, 1983). 
The selective attachment of the cells with the cell-surface galactose to substrate coated 
with a galactose-containing polymer (PV-MeA, Ne Tech) via galactose-bearing 
conjugation with soybean agglutinin (SBA – a galactose-specific lectin), allows to enrich 
the erythroblasts with good yield. As well as erythroblasts, leukocytes and erythrocytes are 
also adsorbed to the slides via SBA (Figure 2). The optimal conditions for isolating 
erythroblasts are possible to be obtained by adjusting the concentration of SBA. 
Using this lectin enrichment based on the FISH analysis, Kitagawa et al. (2002) have 
estimated that 65% of erythroblasts were of fetal origin and average number of 
erythroblasts was 3.4 per 1 ml of maternal blood during normal pregnancy. 
In comparative study Babochkina et al. (2005c) have found 7-fold increase in the yield of 
erythroblasts after lectin enrichment as compared with CD71 enrichment. This indicates 
that the lectin-based method is more efficacious than a MACS approach for the 
enrichment of erythroblasts from maternal blood and that this method may be a 
promising alternative for future investigations concerned with non-invasive prenatal 
diagnosis. 
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Figure 2. Scheme of galactose-bearing conjugation of blood cells via soybean agglutinin (SBA), a galactose-
specific lectin. 
Blood cells are attached to the solid support with PV-MeA, carrying α-1.6 galactose terminal, via SBA. 
Erythroblasts preferentially bind to the solid support with a low concentration of SBA. 
 
 
 
1.3.3. Identification and analysis of the enriched cells 
1.3.3.1. The identification of fetal origin of erythroblasts enriched from 
maternal blood 
To identify the fetal origin of enriched candidate cells it is possible to use morphological 
criteria and labeling for embryonic and fetal haemoglobin (Zheng et al., 1993; Mesker et 
al., 1998; Parano et al., 2001). 
1.3.3.1.1. Morphological properties 
 The erythroblasts have distinct morphometric characteristics such as small, condensed, 
rounded nuclei, big nucleus-cytoplasm (N/C) ratio, which allow differentiate them from all 
other cells.  
Many investigators have suggested that erythroblasts originating from the fetus have 
properties of nuclear morphology that are distinguishable from erythroblasts of maternal 
 
 
NRBC 
PV-MeA 
Galactose on the polymer 
Lymphocyte
yte 
Cell 
Galactose 
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origin (Wang et al., 2000; Samura et al., 2000; Samura et al., 2001; Ikawa et al., 2001). 
Cha et al. (2003) have presented a scoring system based on the distinct phenotypic 
characteristics of the fetal erythroblasts. Two of them are morphological characteristics, 
and another two – characteristics of gamma haemoglobin staining. The study demonstrates 
the ability to identify fetal cells without relying on the presence of the Y chromosome. 
1.3.3.1.1. Fetal haemoglobin labeling 
 Yolk sac erythroblasts synthesize ε-, ζ-, γ- and α-globins, these combine to form the 
embryonic haemoglobins. Between six and eight weeks, the primary site of erythropoiesis 
shifts from the yolk sac to the liver, the three embryonic haemoglobins are replaced by 
fetal haemoglobin (HbF) as the predominant oxygen transport system, and ε- and ζ-globin 
production gives way to γ-,α- and β-globin production within definitive erythrocytes 
(Peschle et al., 1985). HbF remains the principal haemoglobin until birth, when the second 
globin switch occurs and β-globin production accelerates. 
Zheng et al. (1993) suggest that fetal origin of erythroblasts can be confirmed by labeling 
intracytoplasmic, developmentally-specific fetal haemoglobin. Since then, there have been 
several attempts to develop fetal erythroblast specific antibodies for both enrichment 
and/or identification (Zheng et al., 1997; Zheng et al., 1999; Huie et al., 2001). Presently, 
most investigators use γ-globin for fetal cell identification. However, not only fetal 
erythroblasts but also maternal erythroblasts express γ-globin (Pembrey et al., 1973). The 
“leaky” expression of γ-globin in adults prompted Cheung et al. (1996) to suggest the use 
of the embryonic ζ-globin instead. They have demonstrated this principle in the case of 
sickle cell anaemia and also in the case of β-thalassaemia on micromanipulated, ζ-globin 
positive NRBCs enriched from maternal blood between 10-12 weeks. Luo et al. (1999) 
have shown that ζ-globin was present in 53% of definitive erythrocytes between 15-22 
weeks and 34% at term, because its expression is not completely switched off after 
embryonic period. Also, ζ-globin chains exist in adults with the α-thalassaemia trait 
(Chung et al., 1984). 
Mesker et al. (1998) have demonstrated the presence of other embryonic ε-globin positive 
NRBCs in male fetal erythroblasts from two post-CVS maternal blood samples. Mavrou et 
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al. (1999) in comparative study have found that ε-globin was more reliable and specific for 
the detection of the fetal NRBCs than ζ-globin.  
1.3.3.2. The analysis of fetal erythroblasts enriched from maternal blood 
The enriched fetal cells can be analyzed predominantly by polymerase chain reaction 
(PCR) and fluorescence in situ hybridization (FISH). 
1.3.3.2.1. Polymerase Chain Reaction (PCR) 
The main advantage of single-cell PCR based analysis is the good efficiency and 
specificity. The disadvantage is that the collection of single cells needs a lot of experience 
with regard to manipulation and transferring the cells to reaction tubes and is associated 
with a significant loss of the rare fetal cells.  
The ability of PCR to amplify minute quantities of DNA has been exploited by several 
investigators to demonstrate the possibility of prenatal diagnosis of monogenic disorders 
using fetal cells enriched from maternal blood.  
Sekizawa et al. (1996) have demonstrated that it was possible to select single fetal 
erythroblasts by micromanipulation and to potentially diagnose genetic conditions such as 
Duchenne muscular dystrophy by PCR. One limitation of that study was that erythroblasts 
identified by morphology alone were presumed to be fetal. In contrast, Cheung et al. 
(1996) used micromanipulation to pick ζ-globin positive fetal erythroblasts and diagnosed 
fetal haemoglobinopathy in two pregnancies between 10-12 weeks. They avoided the 
problem of allele dropout by pooling several erythroblasts in each PCR reaction. The 
usability of micromanipulation prior to PCR has since been confirmed by Watanabe et al. 
(1998) who demonstrated the prenatal diagnosis of the X-linked ornithine 
transcarbamylase deficiency syndrome and by Samura et al. (2001) who demonstrated the 
adjunctive use of PCR after FISH.  
1.3.3.2.2. Fluorescence in situ hybridisation (FISH) 
The main advantage of the FISH is that the counting of fetal cells could be realized 
automatically in the future. With such automatic analysis it could be possible to examine 
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large number of cells in short time. The disadvantage of FISH for fetal cells is low 
efficiency.  
The ability of FISH to detect fetal aneuploidies within fetal cells isolated from maternal 
blood was demonstrated by many researches. Price et al. (1991) have demonstrated the use 
of FISH technique for diagnosis of the trisomies 18 and 21. Elias et al. (1992a) have 
extended these observations by diagnosing fetal trisomy 21 in the maternal blood taken 
before CVS. The first series was reported by Ganshirt-Ahlert et al. (1993) who confirmed 
five cases of trisomy 18 and ten cases of trisomy 21 in erythroblasts enriched from 
maternal blood. Cacheux et al. (1992) have shown that sex chromosome aneuploidy could 
also be detected reliably and Bischoff et al.  (1995) have detected sex chromosome 
mosaicism by FISH in fetal cells enriched from maternal blood. Finally, Pezzolo et al. 
(1997) have described one case in which fetal triploidy was diagnosed by FISH on 
enriched fetal cells and confirmed by CVS. Some investigators have attempted to increase 
the number of chromosomes that could be analyzed by interphase FISH by performing 
simultaneous multicolour FISH (Bischoff et al., 1998) or by sequential hybridisation of 
chromosome pairs (Zhen et al., 1998).  
 
1.3.4. Clinical trials of non-invasive prenatal diagnosis 
The NICHD (National Institute for Child and Development) funded NIFTY (National 
Institute for Child and Development Fetal Cell Isolation Study), which began in 1994. The 
trial aimed to recruit 3000 women considered to be at “high risk” (women that are over 35 
years, have serum screening results indicating an increased risk of Down Syndrome, have 
fetal anomalies detected on ultrasound and have familial chromosomal rearrangement) for 
fetal aneuploidy. However, studies performed have indicated that fetal erythroblasts cannot 
be reliably isolated and analyzed despite the use of current state-of-the-art technologies. In 
these studies sensitivities as low as 16% were recorded by groups using flow cytometrical 
(FACS) enrichment strategies, whereas those using a magnetic cell sorting (MACS) 
approach were able to detect fetal cells with a sensitivity of 45% (Bianchi et al., 2002). 
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1.3.5. Limitation of clinical application of non-invasive diagnosis 
The disappointing results of detection and analysis of erythroblasts in maternal blood have 
initially been attributed to very low occurrence of erythroblasts within maternal blood 
(Hamada et al., 1993) and to the lack of suitable refined enrichment procedure using fetal 
cell markers specific enough to enrich and identify them. 
The recent studies have, however, indicated that fetal erythroblasts may express certain 
apoptotic traits, such as fragmentation of their nuclear DNA as detected by the TUNEL 
assay (Sekizawa et al., 2000; Kolialexi et al., 2004). This has raised the question of 
whether fetal erythroblasts are suitable for molecular genetic analysis, and have again 
voiced the concern whether these cells can indeed be detectable at all in the maternal 
circulation. 
 
1.3.6. Place of fetal cells in non-invasive prenatal diagnosis 
Currently it is envisaged that fetal cells derived from maternal blood could be used as a 
screening tool, alone or (more likely) in combination with other modalities such as cell-
free DNA biochemical tests and nuchal translucency scans. 
However, two changes in the current state of the art would allow enriched fetal cells to be 
used for screening and, more important, diagnosis. These include reliable enrichment of 
fetal erythroblasts in the first trimester and specific identification of the fetal origin of 
these cells. 
Fetal cells can be used for diagnosis only if a pure population of these cells can be 
obtained, or if there is a method of confirming the fetal origin of the erythroblasts being 
tested and distinguishing them from background maternal (Goldberg, 1997). 
The complete system for using fetal cells from maternal circulation for prenatal diagnosis 
of specific genes as well as chromosomal disorders is likely to be derived from 
investigating the following functional components, some of which may be procedurally 
combined: first, segregation of a population of nucleated blood cells enriched in fetal 
cells of one or more types; second, identification of cells that are probably of fetal origin 
within this population; third, isolation of the cells likely to be of fetal origin; fourth, 
confirmation of the cell(s) as fetal; and, fifth, analysis of the fetal cells (Bayrak-Toydemir 
et al., 2003). 
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Over the past two decades, investigators have developed and pursued strategies that draw 
upon several or all of these components in various combinations and sequences of step, 
but still today performing the cytogenetic and molecular analysis of fetal cell obtained 
non-invasively from maternal circulation is very desirable though elusive goal, and so far 
we have not yet an optimal protocol. 
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2. Results 
30 
2.1. FISH optimization on cord blood samples 
 
Introduction 
The enriched fetal cells can be analyzed by fluorescence in situ hybridisation (FISH) 
(Bianchi et al., 1992; Bischoff et al., 1998; Oosterwijk et al., 1998b; Al Mufti et al., 1999; 
Parano et al., 2001). 
The main advantage of the FISH is that the counting of fetal cells could be realized in the 
future automatically. The disadvantage of FISH for fetal cells is the low efficiency. 
As Troeger et al. (1999b) and many other authors have previously shown the erythroblasts 
isolated by micromanipulation could be reliably analyzed by PCR for a number of fetal 
genetic loci with a disparity appeared to exist between the analysis of fetal erythroblasts by 
PCR and FISH. 
This restriction for successful FISH analysis of erythroblasts circulating in maternal 
blood may be due to the fact that the nuclei in fetal cells are very small, the DNA in these 
cells is very dense, and it means, that access for penetration and hybridization of probes 
is difficult. In such case the major aspects for successful FISH are the kind of fixation, 
pretreatment of cells, choice of probes and optimization of hybridisation conditions. In 
our study we tried to improve the FISH efficiency on MGG stained slides by optimization 
of the FISH protocol. 
The choice of MGG staining was made, because such approach allows the cell 
morphology to be unchanged. The cell morphology helps to recognize the erythroblasts.  
To make easier the access to DNA of erythroblasts we have compared different kinds of 
pretreatment of cells: pepsin, HCl, pro K, and microwave activation. 
A further aspect, which plays a critical role in success of FISH is the choice of 
hybridization probes. We have compared Vysis two-color cocktail: X centromeric α-
satellite (spectrum green)/Y centromeric α-satellite (spectrum orange) and Qbiogene two-
color cocktail: X centromeric a-satellite (fluorescein)/Y centromeric a-satellite 
(rhodamine). Also we checked the probes for Y chromosome for centromeric region 
Yp11.1-q11.1 (α-satellite) and for region q12 (satellite III), alone and in combination. 
Then we used the combination of Qbiogene probes: two-color cocktail: X α-satellite 
(fluorescein) and Y α-satellite (rhodamine) in combination with Y III-satellite 
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(rhodamine) in one–step two–color XYY-FISH-hybridization. To optimize the FISH 
protocols we also checked different conditions of hybridization: melting temperature and 
time, duration of hybridization and washing conditions also. 
 
2.1.1. Pepsin, Proteinase K and HCL pretreatment 
Introduction 
The pepsin and proteinase K digest the protein matrix that surrounds the nucleic acid. The 
precise action of the HCL acid is not known, but it has been suggested, that it is connected 
with extraction of proteins and partial hydrolysis of the target sequence. 
Aim 
We have applied these pretreatments to improve access of the probe to target nucleic acid 
and to reduce non-specific background signals. The pretreatments were supposed to 
improve the efficiency of the FISH on erythroblasts enriched from maternal blood. 
Results 
By examination of different concentrations, temperature and duration of time, the 
following optimal conditions for pepsin pretreatment were determined: 0,005% solution of 
pepsin in water, for 30 sec at 370C. 
The efficiency for FISH on erythroblasts from cord blood under these experimental 
conditions with Vysis probes for MGG slides was 98%. The signals were bright and very 
good recognizable, but the morphology of cells was destroyed. The cells represented only 
nuclei with small rim of cytoplasm (Figure 6). 
Proteinase K and HCL treatments did not produce good results for MGG slides. They have 
demonstrated good FISH signals, but have destroyed the morphology of cells completely. 
After hybridization the slides have high non-specific background signals. 
 
2.1.2. Microwave pretreatment 
Introduction 
The microwave treatment has been suggested to enhance the exposure of the chromosomes 
to FISH probes (Durm et al., 1997). 
The mechanism and the reason for the accelerating of FISH efficiency by microwave 
treatment still are not well understood. It is considered that the microwave treatment 
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produces the local thermal effects which may contribute to DNA denaturation and exerts a 
considerable influence on proteins. 
Aim 
To improve the efficiency of the FISH analysis by the microwave treatment. 
Results 
1) Microwave conditions optimization 
The experimental conditions were systematically optimized using a household 
microwave oven. It was important to place the specimen slide onto a glass filled with 
PBS buffer in order to prevent “overdenaturation” of the sample and to maintain the 
nuclei architecture. The best position of the slide was determined in the centre of circled 
plate since the microwave field is not homogeneous. The best denaturation conditions 
were determined as 700 W for 40 sec (Table 2; Figure 4A).  
 
  
180 W 360 W 700 W 
5 sec       
10 sec       
15 sec       
20 sec       
25 sec       
30 sec       
35 sec       
40 sec       
45 sec       
50 sec       
55 sec       
60 sec       
 
Table 2. Choice of conditions of microwave pretreatment. 
Red color – best conditions; orange – good; yellow – satisfactory; blue – bad. 
 
 
2) The conventional XY Vysis FISH with microwave pretreatment on MGG stained 
erythroblasts from cord blood 
Hybridization was performed with conventional Vysis two-color cocktail XY probes for 
6 hours. The average efficiency of X- and Y- signals on erythroblasts enriched from cord 
blood was 99% (SDev 0.01136, Var 0.00013) (8 cases). Under the same experimental 
conditions without the microwave pretreatment, the average efficiency for MGG-slides 
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was 73%. The fluorescence signals for Y- and X-chromosome were equal and bright, 
without dim, in nucleus position. Morphology of MGG-staining was kept well. 
3) The conventional XY Vysis FISH with microwave pretreatment on 
immunocytochemical (ICC) stained erythroblasts from cord blood 
Microwave pretreatment of the slides was used before FISH under the same experimental 
conditions also for ICC staining slides. The average efficiency of X- and Y-signals on 
erythroblasts enriched from cord blood was 83% (SDev 0.14, Var 0.02) (5 cases). Under 
the same experimental conditions without microwave pretreatment the average efficiency 
for ICC-slides was 65% (Table 3; Figure 3). 
 
2.1.3. Choice of probes for FISH analysis of erythroblasts 
Aim 
To compare Vysis and Qbiogene probes. 
Results 
For the comparison of Vysis and Qbiogene probes we have performed hybridisation with 
Vysis two-color cocktail probes: X centromeric a-satellite (spectrum green)/Y centromeric 
a-satellite (spectrum orange) and Qbiogene two-color cocktail probes: X centromeric a-
satellite (fluorescein)/Y centromeric a-satellite (rhodamine). The average efficiencies were 
75% and 79% for the Vysis and Qbiogene probes, respectively. Further we tried to use for 
our research the Qbiogene probes, because they are more suitable in hybridization and less 
expensive; in addition, the company offers the wide range of different fluorochromes and 
their combinations (Figure 5). 
 
2.1.4. The labeling of Y chromosome by two different probes in the one-step two-
color XYY-FISH 
The mathematical model 
The mathematical calculation of probability of labeling the fetal cells by XY-and XYY-
probes combinations gives the values 0.810 and 0.891, respectively (in the mathematical 
model we took equal FISH efficiency of 90% for X, Y (α-satellite) and Y (III-satellite) 
probes in the mathematical model, as described by the manufacturer). Thus, the labeling 
of Y chromosome by two different probes (α- and III-satellite) of the same color in the 
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one-step two-color XYY-FISH has the advantage in detecting fetal Y-chromosome. 
Theoretically the increase in the number of Y chromosome probes of the same color leads 
to increase in the probability of detection of Y-chromosome.  
Aim 
To test a possible improvement in the detection of Y-chromosome signal by applying 
one–step two–color XYY-FISH-hybridization in which the Y-chromosome was labeled 
by two different probes (α- and III-satellite) of the same color. 
Results 
Firstly, we have checked hybridization efficiency for Y α- and Y III-satellite Qbiogene 
probes. The average efficiencies on cord blood from male were 100% and 90% for Y α- 
and Y III-satellite Qbiogene probes, respectively. 
At the next step, we have compared the efficiency of Qbiogene probes: Y α- (fluorescein) 
and Y III-satellite (rhodamine) in one-step YY-FISH. The hybridization efficiency for both 
probes was the same and was equal to 98% (Figure 7). 
Then, we used the combination of probes: two-color cocktail: X α-satellite (fluorescein) 
and Y α-satellite (rhodamine) in combination with Y III-satellite (rhodamine) in one–step 
two–color XYY-FISH-hybridization. The average efficiency on cord blood from male 
was 100% (Figure 4 B, C, D, E). 
 
2.1.5. Development of a combined immunocytochemistry (ICC) for glycophorin A 
(GPA) (fetal cell identification) and FISH (as genetic diagnosis) protocol on cord 
blood samples 
Introduction 
The glycophorin-A (GPA) antigen has been shown to be expressed over a broad spectrum 
of erythropoietic development, and had previously been used for the highly successful 
enrichment of erythroblasts from maternal blood samples (Troeger et al., 1999a; Al Mufti 
et al., 2004; Choolani et al., 2003). A reason for choosing the GPA antigen and not other 
possible fetal erythroblast specific antigens, such as gamma and epsilon globin 
molecules, is that these latter proteins are frequently not expressed with equal abundance 
in all fetal erythroblasts. 
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The immunocytochemistry and FISH are fundamentally incompatible techniques. The 
harsh fixatives, high temperatures, formamide and stringent washes commonly used in 
FISH results in the protein damage. Conversely, the gentler fixatives used during 
immunocytochemistry hinders probe penetration into the nucleus and give poor FISH 
efficiency (Oosterwijk et al., 1998c). In order to combine the two techniques, every step 
needed to be analyzed separately. 
Aim 
To combine the immunocytochemistry and FISH techniques and to check the limitation 
of sensitivity and the specificity of the combined technique. 
Results 
The hybridisation efficiency of 65% was achieved when applying conventional XY Vysis 
FISH protocol on ICC slides. Unfortunately, cell morphology was poor and most of the 
nuclei and cytoplasm were damaged. In contrast, FISH efficiency when using MGG 
staining was 98%. The hybridisation efficiency on ICC slides can be improved up to 83% 
by using microwave pretreatment (Table 3; Figure3) (See also results of microwave 
pretreatment) 
 
 
 
 
 
Figure 3. XY Vysis FISH on ICC (GPA)-stained erythroblasts from cord blood. 
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Case Time of 
hybridisation, 
hours 
Probe Efficiency, 
% 
1 9 Vysis XY 97 
2 5 Vysis XY 78 
3 5 Vysis XY 76 
4 5 Vysis XY 98 
5 5 Vysis XY 67 
    
  Average 83 
 
Table 3. XY Vysis FISH with microwave pretreatment on ICC (GPA)-stained erythroblasts from cord 
blood. 
 
 
2.1.6. Conclusion of FISH optimization on cord blood samples 
In order to optimize the FISH protocol for hybridization of erythroblast we have tried 
different pretreatments of slides: pepsin, HCl, proteinase K and microwave activation. 
The best results were demonstrated by the microwave activation. This pretreatment 
allows achieving good FISH efficiency with keeping of good cell morphology. All other 
kind of applied pretreatments resulted in destroying the cell morphology which is 
significant disadvantage. 
Next critical aspect, which plays a critical role in the success of the FISH, is the choice of 
hybridisation probes. According to our results, the best FISH efficiency was 
demonstrated by the combination of two probes of the same color (rhodamine) for Y 
chromosome (α- and III-satellite) in combination with X (α-satellite) chromosome probe 
(fluorescein) in one–step two–colour XYY-FISH-hybridisation (Figure 4). 
The combination of the immunocytochemistry and FISH resulted in poor cell 
morphology and reduction of FISH efficiency. The applying of microwave pretreatment 
to ICC slides increases the FISH efficiency, but destroys the cell morphology to a great 
extent. 
Further, microwave and pepsin pretreatments as the best of investigated ones were used 
with XYY-FISH for erythroblasts enriched from maternal blood (See also results of 
“FISH analysis on maternal blood samples”). 
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Figure 6. Vysis XY FISH on cells from cord blood after pepsin preatreatment. 
Figure 7. YcenY III Qbiogene FISH on erythroblasts enriched from cord blood
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2.2. FISH analysis on maternal blood samples 
 
2.2.1. XY Vysis FISH 
Aim 
To perform conventional XY Vysis FISH analysis on memorized erythroblasts enriched 
from maternal blood and to analyze the structure of erythroblast population after FISH.  
Design 
The FISH signal was individually analyzed for every memorized erythroblast. The detected 
signals were noted as XX, XO, or OO (no signal), XY and XYY signals. Also the cases of 
loss of the cells were noted. 
Results 
1) Pregnancy cases with male fetus 
Seven maternal blood samples from pregnant women with male fetus were hybridized with 
Vysis probes, without microwave pretreatment according to the optimized protocols. 
Average number of erythroblasts was 16, ranging from 11 to 20 per slide. We found 
specific XX signal on average in 50.9% of the erythroblasts; XO signal on average in 
16.7% of the erythroblasts; OO signal on average in 21.0% of the erythroblasts; XY signal 
on average in 5.3% of the erythroblasts; XXY signal on average in 2.6% of the 
erythroblasts and loss of cells was determined on average in 3.5% of all memorized 
erythroblasts enriched from maternal blood samples (Table 5). 
2) Pregnancy cases with female fetus 
Seven maternal blood samples from pregnant women with female fetus were hybridized 
with Vysis probes following the optimized protocol. Average number of erythroblasts was 
8, ranging from 2 to 12 per slide. XX signal was found on average in 41.1% of the 
erythroblasts, XO signal was found on average in 5.4% of the erythroblasts, OO signal was 
found on average in 26.8% of the erythroblasts after applying Vysis FISH protocol and 
loss of cells was found on average in 26.6% of all memorized erythroblasts enriched from 
maternal blood samples (Table 6). 
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XX XO OO XY XXY Loss of 
cell
3054-4 Vysis No 6 15 9 4 1 1 2
3074-1 Vysis No 6 11 7 1 1 1 1 3
3065 Vysis No 6 13 9 2 1 1 2
3064 Vysis No 6 14 12 1 1 2
3096 Vysis No 6 11 5 5 1 2
3054-1 Vysis No 6 14 5 2 1 2 2 2 1
3107-2 Vysis No 6 15 4 2 7 2 6
3087-2 Vysis No 6 20 6 2 12 2
Average 15.7 8.4 2.2 4.2 1.6 1.2 2.8 3.0
Sum 113 58 19 24 6 3 4 20
In % 100% 50.9% 16.7% 21.0% 5.3% 2.6% 3.5%
Another cell 
(not 
memorized) 
with Y 
signal
Result of XY Vysis FISH on memorized cellsCase ID Type of 
probes
Pretrea
tment
Time of 
hybridisation
, hour
Number of 
memorized 
erythroblasts 
after MGG 
identification
Table 5. XY-Vysis-FISH analysis of morphologically assessed erythroblasts enriched from maternal blood 
with male fetus 
 
XX XO OO loss of cell
3073 Vysis No 16 2 1 1
3663-4 Vysis No 17 7 4 3
3055 Vysis No 17 12 1 5 6
3023 Vysis No 9 6 2 1 2 1
3114-1 Vysis No 9 8 3 3 2
3105 Vysis No 9 10 6 1 0 3
3104 Vysis No 9 11 6 1 2 2
Average 8.0 3.3 1.0 2.5 2.5
Sum 56 23 3 15 15
in % 100.0% 41.1% 5.4% 26.8% 26.6%
Result of XY Vysis FISH on memorized cells
Case ID Type of 
probes
Pretreatme
nt
Time of 
hybridisati
on, hour
Number of 
memorized 
erythroblasts 
after MGG 
identification
Table 6. XY-Vysis-FISH analysis of morphologically assessed erythroblasts enriched from maternal blood 
with female fetus 
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2.2.2. XYY Qbiogene FISH 
Aim 
To improve the FISH efficiency on erythroblasts enriched from maternal blood by 
applying XYY Qbiogene FISH protocol following the optimization on cord blood and to 
analyze the structure of memorized erythroblast population after FISH.  
Results 
1) Pregnancy cases with male fetus 
Eight maternal blood samples from male pregnant women were hybridized with the 
mixture of Qbiogene two-color cocktail: X centromeric α-satellite (fluorescein)/Y 
centromeric α-satellite (rhodamine) and Qbiogene Y III-satellite (rhodamine) probes, 
following the protocols optimized on cord blood. Average number of erythroblasts was 14, 
ranging from 6 to 19. We found specific XX signal on average in 61.5% of the 
erythroblasts, XO signal on average in 8.3% of the erythroblasts, OO signal on average in 
14.7% of the erythroblasts, XY signal on average in 6.4% of the erythroblasts, XXY signal 
on average in 0.9% of the erythroblasts and loss of cells was determined on average in 
8.1% cells from population of memorized erythroblasts (Table 7). 
2) Pregnancy cases with female fetus 
Eight maternal blood samples from female pregnant women were hybridized with the 
mixture of Qbiogene two-color cocktail: X centromeric α-satellite (fluorescein)/Y 
centromeric α-satellite (rhodamine) and Qbiogene Y III-satellite (rhodamine) probes, 
following the protocols optimized on cord blood. Average number of erythroblasts was 14, 
ranging from 5 to 35. 
XX signal was found on average in 47.8% of the erythroblasts, XO signal was found on 
average in 8.8% of the erythroblasts, OO signal was found on average in 38.9% of the 
erythroblasts and the loss of cells was found on average in 4.4% of the erythroblasts after 
Qbiogene FISH (Table 8). 
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XX XO OO XY XXY Loss of 
cell
3084 QbioXY+Y No 15 16 11 2 3 2
3085 QbioXY+Y No 15 17 13 1 3 3
3011 QbioXY+Y No 15 11 5 3 3 2
3063 QbioXY+Y No 15 11 5 3 3 3
3089 QbioXY+Y No 16 16 8 1 1 1 1 4 2
3091 QbioXY+Y No 16 6 6 5
3083 QbioXY+Y No 16 13 8 1 2 1 1 2
3077 QbioXY+Y No 16 19 11 5 2 1 3
Average 13.6 8.4 1.8 2.7 1.8 1.0 2.3 2.8
Sum 109 67 9 16 7 1 9 22
In % 100.0% 61.5% 8.3% 14.7% 6.4% 0.9% 8.1%
Another 
cell (not 
memorize
d) with Y 
signal
Result of XY Vysis FISH on memorized cellsCase 
ID
Type of 
probes
Pretre
atment
Time of 
hybridisati
on, hour
Number of 
memorized 
erythroblasts 
after M GG 
identification
Table 7. XYY-Qbiogene-FISH analysis of morphologically assessed erythroblasts enriched from maternal 
blood with male fetus 
 
XX XO OO Loss of 
cell
3117 Qbiogene XY-Y No 9 8 7 1
3110 Qbiogene XY-Y No 9 5 5
3111 Qbiogene XY-Y No 9 9 3 1 5
3109 Qbiogene XY-Y No 9 12 8 1 2 1
3062 Qbiogene XY-Y No 9 35 10 2 21 2
3055-2 Qbiogene XY-Y No 9 20 6 1 11 2
3663-2 Qbiogene XY-Y No 9 18 11 3 4
3023-2 Qbiogene XY-Y No 9 6 4 1 1
Average 14.1 6.8 1.4 7.3 1.7
Sum 113 54 10 44 5
In % 100.0% 47.8% 8.8% 38.9% 4.4%
Result of XY Vysis FISH on memorized cellsCase ID Type of probes Pretreat
ment
Time of 
hybridisati
on, hour
Number of 
memorized 
erythroblasts 
after MGG 
identification
Table 8. XYY-Qbiogene-FISH analysis of morphologically assessed erythroblasts enriched from maternal 
blood with female fetus 
42 
2.2.3. XY Vysis FISH on microwave pretreated slides 
Aim 
To improve FISH efficiency on erythroblasts enriched from maternal blood by applying 
microwave pretreatment of slides following the results of optimization on cord blood in 
conventional XY Vysis FISH procedure and to analyze the structure of memorized 
erythroblast population after FISH. 
Results 
Six maternal blood samples from male pregnant women were hybridized with XY Vysis 
probes, with microwave pretreatment following the optimized protocols. Average number 
of erythroblasts was 16, ranging from 10 to 24 per slide. We found specific XX signal on 
average in 50.4% of the erythroblasts, XO signal on average in 14.4% of the erythroblasts, 
OO signal on average in 17.1% of the erythroblasts, XY signal on average in 3.6% of the 
erythroblasts, XXY signal on average in 5.4% of the erythroblasts and loss of cells was 
determined on average in 9.0% of memorized erythroblasts (Table 9; Figure 8A). 
XX XO OO XY XXY loss of 
cell
3054-3 Vysis microwave 6 17 10 3 1 1 2 0
3074-2 Vysis microwave 6 17 8 4 0 3 2 1
3054-2 Vysis microwave 9 14 6 4 2 0 2 3
3094 Vysis microwave 6 10 5 2 1 2 1
3092 Vysis microwave 6 10 10 2
3107-1 Vysis microwave 6 24 8 3 6 1 6 5
3087-1 Vysis microwave 6 19 9 10 3
Average 15.6 8.4 2.4 3.6 1.5 1.3 2.7 2.9
Sum 111 56 16 19 4 6 10 15
In % 50.4% 14.4% 17.1% 3.6% 5.4% 9.0%
Result of XY Vysis FISH on memorized cells
Case ID Type of 
probes
Pretreat
ment 
Time of 
hybridisa
tion, hour
Number 
memorized 
erythroblast
s after MGG 
identification
Another 
cell (not 
memorized
) with Y 
signal
Table 9. XY-Vysis-FISH analysis (microwave pretreatment) of morphologically assessed erythroblasts 
enriched from maternal blood with male fetus 
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10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
XX XY OO XO XYY Loss of
erythroblast
FISH signal
Qbiogene
Qbiogene mw
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
XX XY OO XO XYY Loss of
erythroblast
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A
B
Figure 8. The comparison of microwave pretreatment on morphologically
assessed erythroblasts enriched from maternal blood samples from
male pregnancy cases
A. Fish analysis with Vysis XY-probes
B. Fish analysis with Qbiogene XYY-probes
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2.2.4. XYY Qbiogene FISH on microwave pretreated slides 
Aim 
To improve the FISH efficiency on erythroblasts enriched from maternal blood with male 
fetus using simultaneously the two protocols which show best results on cord blood: 
microwave treatment and applying of Qbiogene probes with double labeling of Y 
chromosome. 
Results 
Seven maternal blood samples from male pregnant women were hybridized with mixture 
of Qbiogene two-color cocktail: X centromeric α-satellite (fluoresceine)/Y centromeric α-
satellite (rhodamine) and Qbiogene Y III-satellite (rhodamine) probes, with pretreatment 
by microwave, following the optimized protocols. Average number of erythroblasts was 
20, ranging from 14 to 24. We found specific XX signal on average in 50.0% of the 
erythroblasts, XO signal on average in 5.0% of the erythroblasts, OO signal on average in 
28.3% of the erythroblasts, XY signal on average in 4.4% of the erythroblasts, XXY signal 
on average in 1.5% of the erythroblasts and loss of cells was determined on average 10.8% 
of all memorized erythroblasts (Table 10; Figure 8B). 
XX XO OO XY XXY Loss of 
cell
3087-3 QbioXY+Y microwave 19 21 3 1 11 1 5 3
3077-2 QbioXY+Y microwave 19 24 5 13 6 5
3083-2 QbioXY+Y microwave 18 14 11 1 1 1 4
3107 QbioXY+Y microwave 18 22 8 1 6 4 1 2 3
3089-2 QbioXY+Y microwave 19 19 13 3 3 4
3084-2 QbioXY+Y microwave 19 18 14 3 1 3
3091-2 QbioXY+Y microwave 18 20 15 1 2 1 1 5
Average 19.71 9.86 1.40 5.57 2.00 1.00 3.00 3.86
Sum 138 69 7 39 6 2 15
In % 100.0% 50.0% 5.0% 28.3% 4.4% 1.5% 10.8%
Case ID Type of 
probes
Pretreatme
nt
Time of 
hybridisati
on, hour
Number of 
memorized 
erythrobla
sts after 
MGG 
Result of XYY Qbiogene FISH on memorized 
cells
Another cell 
(not 
memorized) 
with Y signal
 
Table 10. XYY-Qbiogene-FISH analysis (microwave pretreatment) of morphologically assessed 
erythroblasts enriched from maternal blood with male fetus 
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Figure 9. Comparison of the different NRBC-populations, enriched from
maternal blood samples analysed with different XY-FISH protocols (%)
A. Different FISH protocols on erythroblasts from pregnancy with male fetus.
B. Different FISH protocols on erythroblasts from pregnancy with female fetus. 
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Figure 10. 
A. The structure of erythroblast population from maternal blood with male fetus.
B. The structure of erythroblast population from maternal blood with female fetus.
C. Comparison of of FISH result on erythroblasts enriched from pregnancies with
male and female.
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2.2.5. The separate analysis of erythroblasts population structure for pregnancies 
with male fetus with and without Y signal detected 
Aim  
To compare the structure of memorized erythroblasts population in the case of pregnancy 
with male fetus when the Y signal was detected and those with no Y signal detected.  
Results 
We have separately analyzed the cases of pregnancy (for which XY Vysis, XY Vysis 
mw, XYY Qbiogene, XYY Qbiogene mw protocols were applied) with male fetus (Table 
11), in which the Y signal was determined, and the results of hybridisation, in which no 
Y signal was detected. The analysis of population structure of erythroblasts with Y signal 
shows XX signal on average in 53% and XY signals on average in 10% of erythroblasts. 
The XO was determined on average in 13% of erythroblasts. XXY signal was determined 
on average in 5% of erythroblasts. The absence of any signals was observed on average 
in 13% of erythroblasts and 7% of the cells were lost. The analysis of structure of 
populations with no Y signal has shown that the XX signal was determined on average in 
56% of erythroblasts. The XO signal was determined on average in 12% of erythroblasts. 
The XXY signal was found on average in 1% of erythroblasts and the absence of signals 
was determined on average in 24% of erythroblasts. 7% of the cells were lost during the 
hybridization procedure. 
From the comparison of the structure of populations with Y signals and without those we 
can see considerable increase in percentage of erythroblasts without any signals (OO) in 
those cases when Y signal was not detected up to 24% compared with 13% in cases when 
the Y signal was detected. We can see also the decrease of XXY signals down to 1% in 
cases in which Y signal was not detected compare with 5% in cases in which Y signal 
was detected. All other data are approximately similar (Table 11; Figure 11). 
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FISH  Vysis,  
% 
Vysis, 
 mw, 
% 
Qbiogene 
XcYc-Y III, 
% 
Qbiogene  
XcYc-Y III, 
mw, 
% 
Average,  
% 
Signal 
detected 
No Y 
signal 
Y signal No Y 
signal 
Y signal No Y 
signal 
Y signal No Y 
signal 
Y signal No Y 
signal 
Y signal 
XX 34 64 55 50 73 54 61 43 56 53 
XO 23 15 12 23 8 10 5 5 12 13 
OO 39 6 20 5 14 12 24 29 24 13 
XY 0 9 0 8 0 13 0 10 0 10 
XXY 0 5 4 11 0 2 1 2 1 5 
Lost 
cells 4 3 9 4 5 9 9 11 7 7 
 
Table 11. Comparison of the structure of erythroblast population in pregnancies with male fetus with and 
without detected Y signal (mw refers to microwave treatment) 
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Figure 11. Comparison of the structure of erythroblast population in pregnancies with male fetus in which 
the Y signal was detected and was not.  
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2.2.6. XYY Qbiogene FISH on pepsin pretreated slides 
Aim 
To improve the FISH efficiency on erythroblasts enriched from maternal blood with male 
fetus using together the two protocols which show best results on cord blood: pepsin 
treatment and applying of Qbiogene probes with double labeling of Y chromosome. 
Results 
Eight maternal blood samples from male pregnant women were hybridized with mixture of 
Qbiogene two-color cocktail: X centromeric α-satellite (fluorescein)/Y centromeric α-
satellite (rhodamine) and Qbiogene Y III-satellite (rhodamine) probes, with pepsin 
pretreatment, following the optimized protocols. Average number of erythroblasts was 23, 
ranging from 8 to 69. We found specific XX signal on average in 31.0% of the 
erythroblasts, XO signal on average in 4.4% of the erythroblasts, OO signal on average in 
45.1% of the erythroblasts, XY signal on average in 1.0% of the erythroblasts, XXY signal 
on average in 0% of the erythroblasts with on average 18.5% of all memorized 
erythroblasts being lost (Table 12). 
XX XO OO XY XXY Loss of 
cell
3089-3 QbioXY+Y pepsin 15 17 12 1 3 1
3083-3 QbioXY+Y pepsin 15 17 13 1 3
3087-4 QbioXY+Y pepsin 16 27 4 3 19 1
3002-2 QbioXY+Y pepsin 16 12 7 4 1
2988 QbioXY+Y pepsin 16 8 1 1 1
3084-3 QbioXY+Y pepsin 16 19 8 1 10
3085-2 QbioXY+Y pepsin 16 15 12 1 1 1
2970 QbioXY+Y pepsin 16 69 0 1 55 17
Average 23 7.13 1.33 13.83 1 4.86
Sum 184 57 8 83 1 34
In % 100.0% 31.0% 4.4% 45.1% 1.0% 18.5%
Type of 
probes
Case ID Result of XY Vysis FISH on memorized cellsNumber of 
memorized 
erythroblasts 
after MGG 
identification
Time of 
hybridisati
on, hour
Pretreatme
nt
Table 12. XYY-Qbiogene-FISH analysis (pepsin pretreatment) of morphologically assessed erythroblasts 
enriched from maternal blood with male fetus 
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2.2.7. FISH analysis with Qbiogene Xc and 18c chromosome probes 
Introduction 
Every chromosome in interphase nuclei has special localization, and if, for example, Y 
chromosome was located in the center of the nuclei, the access to it is difficult. On the 
other hand, if Y chromosome is at the periphery of nuclei, it can be lost during procedure 
of hybridization. We performed the hybridization with chromosome 18 centromeric 
probe Qbiogene. Such choice was made, because chromosome 18 has the same size like 
Y chromosome and was established earlier to be located at nuclear periphery (Cremer 
and Cremer, 2001). 
Aim 
To check the hypothesis that efficiency of hybridization depends on chromosome choice 
for the probe. 
Results 
Six maternal blood samples from male pregnant women were hybridized with the mixture 
of Qbiogene X centromeric (rhodamine) and Qbiogene 18 chromosome (fluorescein) 
probes following the optimized protocols. Average number of erythroblasts was 16, 
ranging from 15 to 18. We found specific XX1818 signal on average in 52% of the 
erythroblasts, XX18O signal - on average in 5% of the erythroblasts, XXOO signal - on 
average in 1% of the erythroblasts, XO1818 signal - on average in 9% of the 
erythroblasts, XO18O signal - on average in 8% of the erythroblasts, XOOO signal - on 
average in 1% of erythroblasts and OO1818 signal on average in 1% of erythroblasts. 
OOOO signal was determined on average in 13% with on average 10% of erythroblasts 
from the population of fixed erythroblasts being lost (Table 13; Figure 12). 
The separate analysis of FISH efficiency for X and 18 chromosomes has shown, that XX 
signal was found in 58% erythroblasts, XO signal was found in 18% of erythroblasts and 
OO signal was found in 14% of erythroblasts. We found 1818 FISH signals in 62% of 
erythroblasts, O18 signal - in 13% of erythroblasts and OO signal was found in 15% of 
erythroblasts (Table 14). 
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XX1818 XX18O XXOO XO1818 XO18O XOOO OO1818 OOOO Loss 
of cell
3016 QbioXY+Y No 19 18 3 2 1 3 1 8
3020 QbioXY+Y No 19 18 11 1 1 3 2
3014 QbioXY+Y No 22 15 8 2 2 1 2
3064 QbioXY+Y No 22 16 9 1 6
3063 QbioXY+Y No 22 15 6 2 3 2 2
3065 QbioXY+Y No 20 16 13 3
Average 16.3 8.3 1.7 1 2.3 2.7 1 1 3.3 33.3
Sum 98 50 5 1 9 8 1 1 13 10
In % 100.0% 52.0% 5.1% 1.0% 9.2% 8.2% 1.0% 1.0% 13.3% 10.2%
Number of 
memorized 
erythroblasts 
after M GG 
identification
Result of XX1818 Qbiogene FISH on memorized cellsCase 
ID
Type of 
probes
Pretr
eatm
ent
Time 
of 
hybrid
isatio
n, 
hour
Table 13. XX1818-Qbiogene-FISH analysis of morphologically assessed erythroblasts enriched from 
maternal blood with male fetus 
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Figure 12. Result of Qbiogene FISH with X centromeric and 18 chromosome probes. 
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Analyzed 
FISH signal 
FISH signal 
(in nuclei) 
FISH 
signal, 
% 
Sum for 
analyzed 
FISH signal, 
% 
XX1818 52 
XX18O 5 
XX XXOO 1 58 
XO1818 9 
XO18O 8 
XO XOOO 1 18 
OO1818 1 
OO OOOO 13 14 
Loss of cells  10 10 
XX1818 52 
XO1818 9 
1818 OO1818 1 62 
XX18O 5 
XO18O 8 
O18 OO18O 0 13 
 XOOO 1  
 XXOO 1 
OO OOOO 13 15 
 
Table 14. Separate analysis of FISH with X centromeric and 18 chromosome probes (X- and 18 
chromosome signals were analyzed separately). 
 
 
 
2.2.8. Conclusion: FISH on maternal blood samples 
On average 13 (range 2-24) erythroblasts were recovered from each maternal blood 
sample analyzed following the enrichment with our standard anti-CD71 MACS protocol. 
Following positive identification, the position of each erythroblast on the glass slide was 
electronically marked using an automated location finder. Each cell was then individually 
examined by conventional FISH using conventional Vysis centromeric probes for the X 
and Y chromosomes. This analysis has indicated that in samples obtained from 
pregnancies with male fetuses, on average only 5.3% of the erythroblasts were XY 
positive, while 50.9% were clearly of maternal origin as they contained XX signals. 
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The remaining erythroblasts (>40%) had aberrant or no FISH signals (Table 15; Figure 
13; Figure 14). Although our hybridisation efficiencies on normal lymphoid cells were 
greater than 95%, we consider that these results may have been due to not completely 
optimal FISH procedure. Hence, we tested a variety of conditions, including the use of 
microwave and pepsin pretreatment, as well as a different source of FISH probes 
(Qbiogene) in which two different Y probes (α- and classical-satellite III) were used in 
combination with an α-satellite probe for the X chromosome. These examinations did not 
yield any significant improvements (Table 15). The best result was received by using 
XYY Qbiogene FISH protocol, when on average only 6.4% of the erythroblasts being 
identified as male, while more than 30% of the cells had aberrant or no FISH signals. We 
also have observed that in those cases when no Y positive erythroblasts were detected, 
the number of erythroblasts with no FISH signals increased. These data suggest that some 
erythroblasts can not be hybridized and as a result we can not detect Y chromosome 
signal in pregnancies with the male fetus. 
The inability to examine all erythroblasts by FISH did not appear to be restricted to 
pregnancies with male fetuses, as in pregnancies with female fetuses we also have 
observed that on average only 44.5% of the erythroblasts were XX positive, while the 
remaining erythroblasts had aberrant or no FISH signals (Table 15, Figure 13). In 
addition, this phenomenon was not restricted to the sex chromosomes, as we have 
observed similar results in an analysis of 6 cases for chromosome 18 in FISH 
hybridisation with X- and 18-chromosome probes, since only 52% of the erythroblasts 
were correctly hybridized. It means that the efficiency of hybridization is independent on 
chromosome choice for the probe (Babochkina et al., 2005a). 
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FISH 
probe 
Fetal 
sex 
Nr.  
of 
cases 
Total nr.   
of 
erythroblast 
XX 
% 
XY 
% 
OO 
% 
XO 
% 
XYY 
% 
Loss of 
erythroblasts 
% 
XY Vysis  male 7 113 50.9 5.3 21.0 16.7 2.6 3.5 
XY Vysis      
mw male 6 111 50.4 3.6 17.1 14.4 5.4 9.0 
XYY 
Qbiogene 
male 8 109 61.5 6.4 14.7 8.3 0.9 8.1 
XYY 
Qbiogene 
mw male 7 138 50.0 4.4 28.3 5.0 1.5 10.8 
XYY 
Qbiogene 
pepsin 
male 8 184 31.0 1.0 45.1 4.4 0.0 18.5 
XY Vysis 
female 7 56 41.1 0.0 26.8 5.4 0.0 26.6 
XYY 
Qbiogene 
female 8 113 47.8 0.0 38.9 8.8 0.0 4.4 
 
 
 
 
 
 
 
 
 
Table 15. FISH analysis of morphologically assessed erythroblasts enriched from maternal blood samples 
(mw refers to microwave treatment).  
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Figure 13. FISH analysis of erythroblasts enriched from maternal blood. 
A, B. XX positive erythroblast, characterized by a large nuclear diameter, enriched from
a pregnancy with a male fetus. 
C, D. XX positive erythroblast, characterized by a large nuclear diameter, enriched from
a pregnancy with a female fetus.
E, F. XY positive fetal erythroblast, characterized by an intermediate nuclear diameter, 
enriched from a pregnancy with a male fetus. 
G, H. FISH negative erythroblast, characterized by very small nuclear diameter. 
All images were taken at 630X magnification.
A                B                       C               D
E                  F                      G               H
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Figure 14. Loss of nucleus of erythroblasts during FISH  procedure and OO FISH 
signal.
A. MGG stained cells
B. FISH (signals are bleached) on same cells
C. Gimsa staining of same cells after FISH
D. Examples of loss of nucleus
E. OO FISH signal
A                             B                          C
D                                               E
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2.3. The comparative analysis of the erythroblasts at different oxygen 
concentrations 
 
Hypothesis 
We suggested that fetal erythroblasts undergo a fundamental change when they enter the 
maternal circulation, and that this change in phenotype involves an alteration in the 
morphology of the cells, particularly an alteration in nucleus structure.  
Aim 
To examine whether this change could be attributed to the different oxygen tensions in 
the fetal and maternal circulatory systems. To this aim we have cultured and analyzed 
post-partum cord blood samples under different oxygen concentrations mimicking those 
in fetal and maternal blood (3 and 20 %, respectively). 
Design 
Preincubated and incubated blood cells were thin smeared on glass slides. After drying, 
they were MGG stained. Erythroblasts were then morphologically identified and counted. 
The relative number of erythroblasts was calculated as the number of erythroblasts per 
100 nucleated cells. Then the diameter of nucleus and its circumference for every 
erythroblast were measured. 
Results 
1) Effect of oxygen concentration on the number of erythroblasts 
With the preincubation erythroblasts number designated as 100%, the average number of 
erythroblasts after incubation at 20% oxygen was 50% (range 33–57%). The average 
number of erythroblasts after incubation at 3% oxygen was 85% (range 58–100%). The 
number of erythroblasts decreased significantly after incubation at 20% oxygen (P=0.027 
<0.05; Wilcoxon sign-rank test), whereas the number of erythroblasts did not decrease 
significantly after incubation at 3% oxygen (P=0.066<0.05; Wilcoxon sign-rank test) 
(Table 16; Figure 15). The difference between the results at 3% and 20% is significant 
(P=0.027<0.05; Wilcoxon sign-rank test). 
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Post-partum blood After 3% O2 (24h) After 20% O2 (24h) Case 
Number of 
erythroblas
ts per 100 
nucleated 
cells 
% Number of 
erythroblas
ts per 100 
nucleated 
cells 
% Number of 
erythroblas
ts per 100 
nucleated 
cells 
% 
1 8 100% 8 100% 4 50% 
2 13 100% 13 100% 5 38% 
3 9 100% 8 89% 4 44% 
4 25 100% 23 92% 20 80% 
5 7 100% 5 71% 4 57% 
6 12 100% 7 58% 4 33% 
       
average   11 85% 7 50% 
 
 
Table 16. Effect of oxygen concentration on the number of erythroblasts. 
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Figure 15. Comparison of erythroblasts (percentage) after incubation at 3% and 20% oxygen. 
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2) Effect of oxygen concentration on erythroblast nuclear size 
With preincubation diameter of erythroblasts designated as 100%, the average diameter 
of erythroblasts after incubation at 20% oxygen was 88% (range 84-94%). The average 
diameter of erythroblasts after incubation at 3% oxygen was 99% (range 92-113%). 
This experiment clearly showed that the erythroblast nuclei did indeed shrink 
significantly (P=0.028<0.05; Wilcoxon sign-rank test) at the higher oxygen concentration 
(20%) when compared to the lower oxygen concentration (3%) (P=0.463>0.05; 
Wilcoxon sign-rank test) (Table 17; Figure 16). 
The difference between the results at 3% and 20% is also significant (P=0.028<0.05; 
Wilcoxon sign-rank test). 
Conclusion 
As the maternal circulation is higher in oxygen concentration than fetal circulation, the 
present results suggest that the high oxygen environment of maternal circulation induces 
morphometric changes in fetal erythroblasts transferred to the maternal circulation. This 
morphometric changes can be connected with apoptotic changes resulted in nuclei loss. 
This suggests that high oxygen concentration induces significant decrease in erythroblasts 
number. All this leads to clearance of erythroblasts from the maternal circulation. 
This phenomenon may be important to maintain the pregnancy because persistence of 
fetal cells in maternal circulation would stimulate the maternal immune system 
(Babochkina et al., 2005a). 
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Post-partum blood After 3% O2 (24h) After 20%  O2 (24h) Case 
Diameter, µm in % Diameter, 
µm 
in % Diameter, 
µm 
in % 
1 5.11 100% 5.76 113% 4.45 87% 
2 5.46 100% 5.17 95% 4.60 84% 
3 5.33 100% 4.89 92% 4.63 87% 
4 5.37 100% 5.10 95% 4.63 86% 
5 5.24 100% 4.96 95% 4.66 89% 
6 5.26 100% 5.45 104% 4.93 94% 
       
average   5.22 99% 4.65 88% 
 
 
Table 17. Influence of oxygen concentration on erythroblast nuclear size (average diameter, in µm).  
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Figure 16. Comparison of erythroblast diameter (µm) after incubation at 3% and 20% oxygen.
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Figura 17. Effect of oxygen concentration on NRBCs number (A) and diameter of NRBCs nuclei 
A. The relative number of NRBCs decreased significantly after incubation under 20% oxygen, whereas the 
number of NRBCs did not decrease significantly after incubation under 3% oxygen (Wilcoxon sign-rank 
test, P<0.05). 
B. The diameter of NRBCs decreased significantly after incubation under 20% oxygen, whereas the 
diameter  of NRBCs did not decrease significantly after incubation under 3% oxygen (Wilcoxon sign-rank 
test, P<0.05). 
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Figure 18. Influence of oxygen concentration on erythroblast nuclear size. Cord blood erythroblasts were 
briefly cultured at 3% and 20% oxygen concentrations, after which morphometric characteristics of their 
nuclei were examined. The data are presented by box plots, indicating the median value (line in the box), 
the 75th and 25th percentiles (limits of the box), and the 10 th and 90 th percentiles (upper and lower 
horizontal bars). Outliers are indicated by empty circles.  
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2.4. FISH after incubation at 3% and 20% oxygen concentrations 
Aim 
To determine whether the 24 hours exposure to high oxygen concentration hampered the 
analysis of erythroblasts by FISH. 
Results 
The FISH (vysis XY probe) signals at high oxygen concentration were found in 59% 
(range 25-77%) of erythroblasts, when compared to those at low oxygen concentration 
(average 88%; range 69-94%) and untreated control samples (average 91%; range 86-
95%) (Table 18). 
Conclusion 
The 24 hours exposure at high oxygen concentration has hampered reliable analysis of 
these erythroblasts by FISH (Babochkina et al., 2005a). 
 
 
Case Post-partum 
blood 
3% oxygen 
culture 
20% oxygen 
culture 
1 90% 69% 25% 
2 95% 93% 77% 
3 95% 96% 68% 
4 86% 85% 68% 
5 88% 94% 65% 
6 91% 92% 53% 
    
average 91% 88% 59% 
min 86% 69% 25% 
max 95% 94% 77% 
 
Table 18. The comparison of FISH efficiency (%) before and after incubation at 3% and 20% oxygen. 
 
2.5. Measurements of erythroblasts 
 
Aim and design 
In order to determine why only one fraction of the circulatory erythroblasts was readily 
analyzable by FISH we have examined their morphological characteristics more closely. 
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Then we have compared the morphometric characteristics of FISH positive and FISH 
negative erythroblasts from maternal blood with those of erythroblasts from cord blood. 
Results 
The measuring of 286 erythroblasts from maternal blood was performed. The average 
diameter of nuclei of erythroblasts with XX- and XX1818chromosome signals (in case of 
X 18 chromosome FISH) were 6.5 µm, average circumference of nuclei was 23.17 µm 
and average nucleus/cytoplasm ratio was 0.47 (Table 19). 
The measuring of 10 erythroblasts from maternal blood with XY signal was performed. 
The average diameter of nuclei of erythroblasts with XY signals was 6.22 µm, average 
circumference of nuclei was 22.95 µm and average nucleus/cytoplasm ratio was 0.51. 
The measuring of 21 erythroblasts from maternal blood with XO signal was performed. 
The average diameter of nuclei of erythroblasts with XO signals was 6.22 µm, average 
circumference of nuclei was 22.67 µm and average nucleus/cytoplasm ratio was 0.43. 
127 cells without any hybridization signals (OO) show average diameter of nuclei 4.92 
µm, average circumference 18.10 µm and average nucleus/cytoplasm ratio was 0.28 
(Table 19). 
The statistic analysis using the T-test shows that differences in the diameter average size 
of nuclei with XX FISH signals and those without FISH signals (OO) are statistically 
significant (p=1.044exp-14<0.05). Also, T-test shows that the differences in the average 
circumference of nuclei with XX FISH signals and those without FISH signals are 
statistically significant (p2.31exp-17=<0.05). The statistic analysis using the ANOVA 
test shows that differences in the diameter, circumference and nucleus/cytoplasm (N/C) 
ratio of erythroblasts from maternal blood: with XX signals, those without FISH signal 
and erythroblasts from cord blood are statistically significant (P<0.0001 for all cases). 
Conclusion 
The morphometric analysis has indicated that those erythroblasts in maternal blood which 
had been hybridized efficiently had a significantly larger nuclear diameter and 
circumference and N/C ratio than those which had been impervious to the FISH 
procedure (Babochkina et al., 2005a). The erythroblasts which had been impervious to 
the FISH procedure are significantly different also from erythroblasts in cord blood  
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Type of 
measurements  
Maternal blood Cord blood 
  
with XX 
signal 
(number of 
measured 
cells) 
without signal 
(number of 
measured 
cells)  
Average 
diameter 
female 
pregnancy 
average 6.31  
mode 6.60  
(n=84) 
average 4.53 
mode 4.20  
(n=60)   
  male pregnancy 
average 6.62  
mode 6.70  
(n=155) 
average 4.92 
mode 5.20 
(n=59) 
average 5.96 
mode 5.80  
(n=106) 
  
18 X 
chromosome 
hybridization 
average 6.59  
mode 6.24 
(n=47) 
average 5.32 
mode 5.50   
(n=8)   
  average 
average 6.50 
mode  6.51     
(n=286) 
average 4.92    
mode 4.97    
(n=127) 
average 5.96
mode 5.80  
(n=106) 
         
Circumference 
female 
pregnancy 
average 22.39 
mode        21.70 
average 16.45 
mode        16.70  
  male pregnancy 
average 24.22 
mode        22.60 
average 18.61 
mode        16.60 
average 21.93 
mode        21.60 
  
18 X 
chromosome 
hybridisation 
average 22.90 
mode        24.71 
average 19.24 
mode        19.00  
  average 
average 23.17 
mode   23.00   
(n=286 ) 
average 18.10    
mode   17.43  
(n=127 ) 
average 21.93 
mode 21.60 
(n=106 ) 
         
         
N/C ratio 
female 
pregnancy 
average 0.49 
mode          0.50 
average 0.26 
mode          0.30  
  male pregnancy 
average 0.48 
mode          0.50 
average 0.26 
mode          0.20 
average 0.32 
mode          0.30 
  
18 X 
chromosome 
hybridisation 
average 0.45 
mode          0.50 
average 0.31 
mode          0.30  
  average 
average 0.47 
mode  0.50       
(n= 286) 
average 0.28    
mode  0.27       
(n= 127) 
average 0.32 
mode 0.30     
(n= 106) 
 
Table 19. Measurements of diameter, circumference and nucleus/cytoplasm (N/C) ratio of erythroblasts in 
maternal and cord blood. 
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Average diameter
6.50
4.92
5.96
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
with signal without signal Cord blood
 
A 
Circumference
23.17
18.10
21.93
0.00
5.00
10.00
15.00
20.00
25.00
with signal without signal Cord blood
 
B 
N/C ratio
0.47
0.28
0.32
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
with signal without signal Cord blood
 
C 
Figure 20. 
A. Comparison of erythroblasts diameter measurement in maternal blood (cells with and without signal) 
and in cord blood. 
B. Comparison of erythroblasts circumference measurement in maternal blood (cells with and without 
signal) and in cord blood. 
C. Comparison of erythroblasts N/C measurement in maternal blood (cells with and without signal) and in 
cord blood. 
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Figure 21. Measurement of erythroblasts  
Red pointers. Measurement of diameter. 
Blue pointer. Measurement of circumference of nucleus. 
Green pointer. Measurement of circumference of cell. 
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2.6. Deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling 
(TUNEL) analysis of erythroblasts 
 
2.6.1. TUNEL and FISH analysis of erythroblast nuclei in cord blood 
Aim 
Since the differentiation of erythroblasts into enucleated erythrocytes involves 
fragmentation of the nuclear DNA, which can be detected by the TUNEL assay, we next 
examined the presence of fragmented DNA (TUNEL positive signal in the nucleus) in 
erythroblasts from cord blood in correlation with result of FISH analysis of these cells. 
Design 
Lymphocyte fraction was isolated by Ficoll, MGG–stained and 2 slides from each case 
were used for FISH (Vysis XY probe) and 2 slides for TUNEL. 
Results 
Our analysis of erythroblasts in cord blood indicated that although a high proportion of 
these erythroblasts were TUNEL positive (57.3%), almost all erythroblasts could be 
reliably analyzed by FISH (83.2%) irrespective of being TUNEL positive or negative. Of 
interest is that our analysis of these post-partum cord blood erythroblasts has indicated 
that these cells had relatively large nuclear diameter and circumference (average = 6.0 
µm and 21.93 µm), which is larger than the group of erythroblasts in maternal blood 
which could not be analyzed by FISH (average diameter = 4.7 µm and average 
circumference = 17.5 µm) (Table 20). 
Case 
Gender TUNEL 
positive cells 
(%) 
FISH    
positive cells 
(%) 
1 male 64.0 94.0 
2 male 65.0 84.0 
3 male 61.5 100.0 
4 male 60.5 66.0 
5 male 71.0 83.0 
6 male 56.0 60.0 
Average male  63.0 81.2 
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Case 
Gender TUNEL 
positive cells 
(%) 
FISH   
 positive cells 
(%) 
8 female 43.0 86.5 
9 female 49.0 86.0 
10 female 53.0 87.5 
11 female 44.0 83.0 
12 female 63.5 85.5 
Average female  50.5 85.7 
Total average  57.3 83.2 
 
Table 20. TUNEL and FISH analysis of erythroblasts in cord blood. 
 
2.6.2. TUNEL analysis of erythroblast nuclei in maternal blood 
Aim 
To examine the presence of fragmented DNA (TUNEL positive signal in the nucleus) in 
erythroblasts enriched from maternal blood and to analyze these results in correlation 
with nuclear size of these cells. 
Results 
69 erythroblasts enriched from 10 maternal blood samples were recorded and measured 
(Axiovision 3.1, Carl Zeiss, Zürich, Switzerland), and then the TUNEL assay was 
applied. This analysis has demonstrated that approximately 69% of erythroblasts with 
nuclei having the diameter larger than 5.6 µm were negative for the TUNEL assay, 
whereas almost 92% of those with the diameter smaller than this value contained 
fragmented DNA (Table 21; Figure 22; Figure 23).  
This latter phenomenon supports the notion that erythroblasts with a small nuclei 
containing fragmented DNA are of fetal origin, as it has previously been shown that these 
cells become TUNEL positive upon entering the maternal circulation.  
Conclusion 
These results suggest that the presence of a dense nucleus rather than a nucleus 
containing fragmented DNA hinders the effective analysis of erythroblasts by FISH 
(Babochkina et al., 2005a). 
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92%
31%
8%
69%
0%
20%
40%
60%
80%
100%
Small nuclei (like FISH
negative)
Big nuclei   (like FISH
positive)
TUNEL positive
TUNEL negative
 
Figure 22. TUNEL analysis and diameter of erythroblast nuclei.     Table 21. TUNEL analysis and diameter 
of erythrocytes. 
 
A B
C D
 
Figure 23. Examination of erythroblast nuclear size and presence of fragmented nuclear DNA in maternal 
blood.  
A, B. Erythroblast with a small dense nucleus which is TUNEL positive.  
C, D. Erythroblast with a large nucleus which is TUNEL negative. All image were taken at 630X 
magnification. 
Parameter Small 
nuclei (like 
FISH 
negative) 
Big nuclei   
(like 
FISH 
positive) 
Average 
diameter 
under or 
equal 5.6 
above           
5.6 
     
Number of cells 24 45 
   
TUNEL 
positive 92% 31% 
TUNEL 
negative 8% 69% 
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2.7. Detection of fetal cells in whole blood 
 (Detection of fetal cells in maternal blood using a combination of two different Y 
chromosome-specific and a single X chromosome-specific FISH probes) 
 
The mathematical model 
The mathematical calculation of probability of labeling the fetal cells by XY-, YY-and 
XYY-probes combinations gives the values 0.81, 0.81 and 0.891, respectively (we took 
equal FISH efficiency of 90% for X, Y (α-satellite) and Y (III-satellite) probes in the 
mathematical model, as described by the manufacturer). Thus, the labeling of Y 
chromosome by two different probes (α- and III-satellite) of the same color in the one-
step two-color XYY-FISH has the advantage in detecting fetal Y-chromosome over other 
methods of labeling mentioned above. Theoretically the increase in the number of Y 
chromosome probes of the same color leads to increase in the probability of Y-
chromosome detection.  
Aim 
To test a possible improvement in the detection of Y-chromosome signal of fetal cells in 
maternal blood by applying one–step two–color XY-FISH-hybridization in which the Y-
chromosome was labeled by two different probes (α- and III-satellite) of the same color 
and to compare the results of XYY-FISH with conventional two-color XY-FISH 
protocol. 
Results 
Our blinded manner analysis of the 19 maternal blood samples by the combination of two 
Y chromosome-specific FISH probes in combination with a FISH probe for the X 
chromosome (XYY-FISH) has indicated that male fetal cells could be detected with 75% 
specificity and 91% sensitivity (Tables 22; Table 23), indicating that male fetal cells 
could be detected in 10 out of the 11 pregnancies with male fetuses. 
Our parallel analysis of 9 of these samples by conventional XY-FISH has indicated that 
male fetal cells could be detected with 50% specificity and 60% sensitivity (Tables 22; 
Table 23). On the other hand, when the same samples were analyzed by our new XYY-
FISH approach male fetal cells could be detected with 100% specificity and 100% 
sensitivity (Table 23). Therefore, the use of two different Y chromosome-specific FISH 
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probes in combination with an X chromosome-specific FISH does appear to yield a better 
result than that obtained by conventional XY-FISH. Furthermore, it appeared that more 
male fetal cells were detected by the XYY-FISH approach, where 1 to 4 fetal cells were 
recorded per slide, (yielding an average concentration of between 8 to 32 fetal cells per 
ml of maternal blood), compared to 1 to 2 fetal cells recorded per slide using 
conventional XY-FISH (Table 22; Table 23). We also have observed that the signals for 
the Y chromosome were more readily identifiable using the XYY-FISH approach when 
compared to those detected by conventional XY-FISH (Figure 24; Figure 25). 
Conclusion 
In our present study we demonstrated the results which confirm our mathematical 
prediction. This XYY detection system has demonstrated the real improvement as 
compared to conventional one (Babochkina et al., 2005b).  
 
Case Gestation Number of male 
fetal cells detected 
by XYY-FISH 
(in 1 ml) 
Number of male 
fetal cells detected 
by XY-FISH 
 (in 1 ml) 
Gender 
1 37+2 24 12 male 
2 26+4 16 12 male 
3 12+1 0 8 f.p. female 
4 12+4 0 0 female 
5 12+0 0 8 f.p. female 
6 14+3 0 0 female 
7 26+4 32 0 male 
8 25+1 32 0 male 
9 28+2 32 20 male 
10 12+3 8 f.p. n.t. female 
11 16+1 0 n.t. male 
12 35+0 0 n.t. female 
13 20+0 8 n.t. male 
14 20+2 16 n.t. male 
15 37+2 32 n.t. male 
16 14+5 8 n.t. male 
17 26+2 0 n.t. female 
18 25+3 24 n.t. male 
19 13+3 8 f.p. n.t. female 
 
Table 22. Detection of male fetal cells by two different FISH strategies. (f.p. – false positive, n.t. – not 
tested). 
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QbioXY+Y 
   
     19 cases   gender  
          male female  
      male 10 2 12 
      FI
SH
 
female 1 6 7 
        11 8 19 
           
       false positive 25%   
       
false 
negative 9%   
           
           
  
 
    sensitivity 91%   
  
 
    specificity 75%   
  
 
     
 
  
           
Vysis XY  
    
QbioXY+Y 
   
9 cases   gender   9 cases   gender  
    male female       male female  
male 3 2 5  male 5 0 5 
FI
SH
 
female 2 2 4  FI
SH
 
female 0 4 4 
  5 4 9    5 4 9 
           
 
false 
positive 40%     false positive 0%   
 
false 
negative 50%     
false 
negative 0%   
           
           
 sensitivity 60%     sensitivity 100%   
 specificity 50%     specificity 100%   
           
 
 
 
 
 
 
 
Table 23. Sensitivity and specificity of XYY- and XY- FISH. 
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Figure 24 A, B. Detection of a male fetal cell in maternal blood by conventional
XY-FISH.
A B
Figure 25 A, B. Detection of a male fetal cell in maternal blood by the use of two Y 
chromosome-specific (α- and III-satellite) FISH probes in combination with a FISH 
probe specific for the X chromosome (XYY-FISH). 
A B
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2.8. Evaluation of Soybean Lectin-based method for the Enrichment of 
erythroblasts 
 
Introduction 
Different approaches have been proposed for the enrichment of erythroblasts from 
maternal blood. However, none of these methods has been shown to obtain fetal cells 
from maternal blood with sufficient reliability for routine prenatal diagnosis. Recent 
studies have indicated that enrichment based on galactose-bearing conjugation may lead 
to more promising results.  
Erythroblasts express galactose on cell surface to a larger extent than other cell types. 
The selective attachment to substrate coated with a galactose-containing polymer (PV-
MeA, Ne Tech) via soybean agglutinin, a galactose-specific lectin, allows enrich the 
erythroblasts (Kitagawa et al., 2002). 
Aim 
To evaluate Soybean Lectin-based method we have performed a comparative study on  
maternal blood samples, with one half of the blood sample being subjected to enrichment 
by standard CD-71 MACS protocol and the other half being enriched by the lectin 
protocol.  
Design 
The lectin enrichment and the MACS/CD 71 methods were performed as described 
previously (Kitagawa et al., 2002) and (Troeger et al., 1999a). In both instances the 
enriched cells were stained with MGG and the number of recovered erythroblasts was 
scored. The cells with low nucleus-to-cytoplasm ratio, dense and small nucleus, and 
orthochromatic, non-granular cytoplasm were considered as erythroblasts at light 
microscopy analysis (Axioplan 2, Carl Zeiss, Zürich, Switzerland). 
The number of erythroblasts on slides isolated by CD-71 MACS enrichment was 
accounted for 2 cytospin slides (2 x (1 x 105 cells)) and recalculated for 1 ml of maternal 
blood. The number of erythroblasts in 1 ml of maternal blood after SBA-lectin 
enrichment was recalculated after analysis for 1 chamber (2 x 106 cells) 
Results 
The average number of erythroblasts after CD 71 enrichment was 2.4 cells (range 0-6) 
per 1 ml of maternal blood. The average number of erythroblasts after SBA-lectin 
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enrichment was 15.7 cells (range 2-59) per 1 ml of maternal blood. Our results (Table 23; 
Figure 25; Figure 26) indicate that significant differences (p=0.0033<0.05; Wilcoxon 
signed rank test for paired samples) exist between the two enrichment methods, with 
almost 7 fold more erythroblasts being recovered per ml of maternal blood by the SBA-
lectin method  when compared with standard MACS approach. 
Another apparent advantage of the SBA-lectin method is that the enriched cells appeared 
to have a better morphology, facilitating easier recognition and analysis, than cells which 
had been treated by the MACS protocol. This aspect is to be explored in an extended 
study. 
Conclusion 
Although the efficiency of the erythroblast recovery by MACS that we have achieved in 
this study is comparable with the data from other studies, it is clear that the SBA-lectin 
method offers a better recovery. The present study also serves to indicate that numerous 
erythroblasts are therefore being lost during the MACS procedure. In this regard, it has 
previously been calculated, that cell loss due to centrifugation can be as high as 2-4% and 
that the most significant loss (almost 10-20%) occurred during the transfer of enriched 
cells onto microscope slides by cyto-centrifugation (Oosterwijk et al., 1998a). It is also 
likely that target cells are lost during the MACS procedure, in that they may be retained 
by the column or lost during the washing steps. Hence, it is possible, that the lack of such 
steps may contribute to the overall improved recovery by the SBA-lectin method. 
Our results suggest that SBA lectin-mediated procedures may provide a better 
opportunity for the enrichment of rare fetal erythroblasts from maternal blood. Our 
preliminary FISH results on lectin- enriched erythroblasts demonstrated a better FISH 
signal quality (Figure 27). 
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Figure 25. Comparison of enrichment efficiency: CD-71 MACs vs Lectin. 
Table 23. Comparison of enrichment efficiency: CD-71 MACs vs Lectin 
 
A B
 
Figure 26. A. MGG stained erythroblasts from maternal blood after CD-71 B. Lectin-based enrichment. 
Case Gestation 
age 
Erythroblasts 
in 1 ml 
Maternal 
blood CD 71 
Erythroblasts 
in 1 ml 
Maternal 
blood Lectin 
1 36+6 0.0 1.6 
2 15+4 1.4 9.4 
3 27+6 6.2 58.9 
4 12+5 0.9 5.1 
5 12+3 0.2 7.4 
6 14+6 3.0 6.0 
7 40+0 2.7 18.4 
8 36+1 4.5 34.3 
9 35+6 4.6 18.3 
10 14+2 0.4 6.0 
11 12+4 2.4 6.8 
    
 Average 2.4 15.7 
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Figure 27. FISH analysis of 
cells enriched from
maternal blood by lectin-
based method. 
A, B, C.  XY positive cells
(proK treatment). 
D.  XY positive 
erythroblast. 
E. FISH negative 
erythroblast
A
B
C
D
E
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2.9. Spectral morphometric comparative analysis of erythroblasts from 
maternal and cord blood 
 
Aim 
The present study is the attempt to identify and evaluate erythroblasts from maternal and 
cord blood using technique of spectrally resolved image analysis. 
Design 
Firstly we determined the localization of different spectral components in nuclei and 
cytoplasm of erythroblasts cells from maternal and cord blood stained with MGG 
employing classification algorithm based on minimal square error matching (MSE). Then 
we compared the chromatin and cytoplasm organization for erythroblasts from maternal 
and cord blood using the computational morphometrical analysis of spectral map. 
Results 
Spectral imaging was performed on MGG-stained blood specimens from 8 cord blood 
(93 cells) and from 12 maternal blood samples (53 cells).  
Figure 29A and 29C show the spectral cube image of some MGG-stained erythroblasts 
from cord and maternal blood, respectively. Using the spectra library, all cells in the 
database were scanned and to each nuclear domain there were assigned the color of the 
library spectrum most similar to its spectral characteristics. The scan produced a 
classified image for each cell using a classification algorithm, as described in Materials 
and Methods.  
Several examples of pseudo-colored spectral mapped images of cord and maternal blood 
cells are shown in Figure 29B and 29D, respectively. The classified images represent the 
spectrally similar regions with the match to the reference spectra of the library.  
The spectral classified image reveals the visually distinct spectral regions in each cellular 
compartment and has demonstrated that erythroblasts from maternal and cord blood 
displayed distinct spectral characteristics. 
To create the histograms of spectral distribution, the computational morphometric 
measurements were performed on the spectrally classified images for 53 erythroblasts 
from maternal blood and 14 ones from cord blood. The area of all spectra domains of the 
nuclei was calculated. The pixels within the distinct nuclear spectral domains were used 
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also to generate histograms that represent relative area of spectral domain in percentage. 
An analysis of the nuclear color content is shown in Figure 28. An inspection of the color 
histograms reveals that the dominant spectrum (67%) in maternal blood erythroblasts was 
the spectrum designated as number 1 (No. 1) in spectral library, while in cord blood 
erythroblasts the spectrum No. 1 was not so dominant, (40% only). Spectrum No. 2 was 
represented by contrast in 16% of maternal blood and in 42% of cord blood erythroblasts. 
Spectrum No.3 was represented in approximately same percentages for maternal and cord 
blood, 17% and 18%, respectively. It means that difference between the nuclei of 
erythroblasts from maternal and cord blood on spectral level is in the distribution of 
spectra 1 and 2. We consider that spectrum No. 1 can correspond to condensed chromatin 
in the nuclei.  
For detailed analysis of spectral domain No.1, as marker of condensed chromatin, we 
have performed measurements on 93 erythroblasts from cord blood and 53 erythroblasts 
from maternal blood. The spectral domain was found in 97% of erythroblasts from cord 
blood and in 100% of erythroblasts from maternal blood. The spectral domain No.1 did 
not appear in the nucleus of 3% of the cord blood erythroblasts, for which only spectral 
domains No. 2, 3 were found.  
Statistical analysis (t-Test) has revealed significant differences (p≤0.0001) in the 
distribution of spectra No.1 between maternal and cord blood erythroblasts. 
Table 24 presents relative area in % of the spectral domain No.1 in the nuclei of 
erythroblasts from maternal and cord blood in connection with results of morphometric 
measurements of diameter, circumference and nuclei-cytoplasm ratio and FISH results 
(results partially published by (Babochkina et al., 2005a).  
For analysis of spectrum No. 4, as marker of cytoplasm content, we performed 
measurements on same cells (53 and 93 erythroblasts from maternal and cord blood, 
respectively).  
The morphometrical analysis of distribution spectrum of No.4 as a marker of cytoplasmic 
content, for this cells has revealed that this spectrum was observed for 93% of 
erythroblasts from cord blood (on average 26% of cytoplasm area) and for 99% of 
erythroblasts from maternal blood (on average 45% of cytoplasm area). The difference in 
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distribution of spectrum No.4 in cells from the two classes is statistically significant (t-
Test, p≤0.0001).  
 
Analysis Cord blood Maternal blood 
FISH analysis vysis XY probe, 
efficiency , % 98% 
xx-51% 
xy- 5% oo-21% 
diameter 5.96 6.47 4.73 
circumference 21.93 23.31 17.53 
Morphometric 
analysis 
N/C 32% 47% 28% 
Spectral analysis Spectrum No.1 
(red in nuclei) on 
average 40%  67% 
 Spectrum  No.4 
(green in 
cytoplasm) on 
average 26%  45% 
 
Table 24. Comparison of erythroblasts in cord and maternal blood by FISH, morphometric measurements 
and spectral imaging analysis. 
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Figure 28. Spectral arrays for erythroblasts from: A. maternal blood; B. cord blood. Area of each spectrally 
similar region in the nucleus was calculated and represented as the percentage of the nuclear area 
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A B C D
Figure 29.  Spectral imaging and spectral classification of erytroblasts
A, C.  Spectral cube imaging of erythroblasts from cord and maternal blood, 
correspondingly.  
B, D.  Pseudo-colored spectral mapped images same cells from cord and maternal
blood, correspondingly, after applying a classification algorithm. Each coloured
domain represents a spectrally similar region.
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2.10. Single cell Taqman PCR analysis of erythroblasts isolated using 
Laser Microdissection and Pressure Catapulting (LMPC) technology 
 
Introduction 
The enriched fetal cells can be isolated by micromanipulation and analyzed by single cell 
Taqman PCR (Troeger et al., 1999b). The analysis of single cells will always be 
hampered by limiting amount of target template. The several strategies can be adopted to 
overcome this problem, including optimization of microdissection (using slides with and 
without membrane), application of different cell lysis protocols, choice of Taqman 
probes, raising the denaturation temperature.  
In our study we tried to optimize the single cell Taqman PCR analysis firstly on cord 
blood. Next we have applied the best protocol for analysis of erythroblasts with small 
dense nucleus from maternal blood. 
 
2.10.1. Taqman PCR analysis of erythroblasts microdissected from cord blood 
 
Aim 
To optimize the Taqman PCR analysis of erythroblasts microdissected by PALM laser-
mediated micromanipulation system from cord blood (from slides with and without 
membrane) by using different choice of probes. 
Design 
The erythroblasts from cord blood were transferred onto glass slides with and without 
membrane by cytocentrifugation and MGG stained. Single erythroblasts were isolated by 
the LPC microdissection method and examined by a multiplex Taqman PCR which had 
been optimized for the analysis of single cells. 
In order to optimize protocol of cell collection we have tried the PALM microdissection 
of erythroblasts from glass slides with and without membrane. To optimize the Taqman 
protocol for amplification of single cells we have used SRY labeled with fluorochrome 
FAM (SRY-FAM) and GAPDH labeled with fluorochrome VIC (GAPDH-VIC) probes 
for to detect the fetal loci and to control the PCR reaction, respectively. The control loci 
had previously been shown to be very effective in monitoring the efficacy of the PCR 
reaction and in ascertaining whether a single cell had indeed been transferred to the 
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reaction vessel. The efficiency for single cell Taqman PCR analysis was tested for every 
probe alone and for their combination. Besides, we have tested the 21 chromosome and 
18 chromosome specific probes as control of DNA amplification in combination with 
SRY probe.  
Results 
Thirty two erythroblasts were collected by PALM microdissection from membrane slides 
and analyzed by single cell Taqman PCR analysis with GAPDH–VIC probes. The 
amplification efficiency was 43.3% (Table 25). 
Case Number of 
microdissected 
cell 
Number of 
GAPDH-
VIC positive 
cells 
Efficiency, 
% 
1 20 9 45.00 
2 12 5 41.67 
    
SUM 32 14 43.33 
 
Table 25. Single cell Taqman PCR analysis with GAPDH-VIC probe on erythroblasts microdissected from 
cord blood 
 
Forty erythroblasts were collected by PALM microdissection from membrane slides and 
analyzed by single cell Taqman PCR analysis with SRY-FAM probes. The amplification 
efficiency was 64.6% (Table 26). 
Case Number of 
microdissected 
cell 
Number of 
SRY-FAM 
positive cells 
Efficiency, 
% 
1 24 16 66.67 
2 16 10 62.50 
    
SUM 40 26 64.58 
 
Table 26. Single cell Taqman PCR analysis with SRY-FAM probe on erythroblasts microdissected from 
cord blood 
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The multiplex Taqman PCR analysis with SRY-FAM and GAPDH–VIC probes was 
performed for 62 erythroblasts, collected in the same way. The amplification efficiency 
was 28.0% and 53.8% for GAPDH and for SRY loci, respectively. In total, the amount of 
Taqman positive cells was 53.8% (Table 27). 
 
Case Number 
of 
microdiss
ected cell 
Number of 
GAPDH-VIC 
positive cells 
GAPDH 
efficiency, 
% 
Number of 
SRY-FAM 
positive 
cells 
SRY 
efficiency, 
% 
Taqman 
positive 
cells, % 
1 30 3 10.00 9 30.00 30.00 
2 16 4 25.00 9 56.25 56.25 
3 16 8 50.00 12 75.00 75.00 
       
SUM 62 15 28.33 30 53.75 53.75 
 
Table 27. Single cell multiplex Taqman PCR analysis with GAPDH-VIC and SRY-FAM probes on 
erythroblasts microdissected from cord blood 
 
The multiplex Taqman PCR analysis with SRY-VIC and 21 chromosome-FAM probes 
was performed for 32 erythroblasts, collected by PALM microdissection from membrane 
slides. The amplification efficiency was 34.4% and 87.5% for SRY and for 21 
chromosome loci, respectively. In total the amount of Taqman positive cells was 87.50% 
(Table 28). 
 
Case Number of 
microdissec
ted cell 
Number of 
SRY-VIC 
positive 
cells 
SRY 
efficiency, 
% 
Number of 
21chromoso
me-FAM 
positive cells 
21 
chromosom
e efficiency, 
% 
Taqman 
positive 
cells, % 
1 16 2 12.50 14 87.50 87.50 
2 16 9 56.25 14 87.50 87.50 
       
SUM 32 11 34.38 28 87.50 87.50 
 
Table 28. Single cell multiplex Taqman PCR analysis with SRY-VIC and 21 chromosome FAM probes on 
erythroblasts microdissected from cord blood. 
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The multiplex Taqman PCR analysis with SRY-FAM and 18 chromosome-VIC probes 
was performed for 68 erythroblasts, collected by PALM microdissection from slides 
without membrane. The amplification efficiency was 18.1% and 32.5% for SRY and for 
18 chromosome loci, respectively. In total the amount of Taqman positive cells was 
35.56% (Table 29). 
 
Case Number of 
microdissec
ted cell 
Number of 18 
chromosome-
VIC positive 
cells 
18 
chromosome 
efficiency, % 
Number 
of SRY-
FAM 
positive 
cells 
SRY 
efficiency, 
% 
Taqman 
positive 
cells, 
% 
1 24 7 29.17 4 16.67 33.33 
2 20 7 35.00 5 25.00 40.00 
3 24 8 33.33 3 12.50 33.33 
       
SUM 68 22 32.50  18.06 35.56 
 
Table 29. Single cell multiplex Taqman PCR analysis with 18 chromosome VIC and SRY-FAM probes on 
erythroblasts microdissected from cord blood. 
 
Conclusion  
The best efficiency of single cell Taqman PCR for detection of Y chromosome was 
achieved when SRY probe labeling by FAM was applied. Therefore, the isolation of 
single cells by PALM from slides with membrane is more effective than that from slides 
without membrane. A major factor to consider here is that membranes prevent the cell 
from damaging during transfer.  
 
2.10.2. Taqman PCR analysis of erythroblasts microdissected from maternal blood 
 
Aim 
To analyze the origin of erythroblasts from maternal blood with small dense nuclei and 
resistant for FISH analysis. 
Design 
For experiment 1 the CD 71 enriched erythroblasts from maternal blood were transferred 
onto glass slides without membrane by cytocentrifugation and MGG stained. Single 
87 
erythroblasts with small dense nucleus, which were resistant to FISH analysis were 
isolated by the LPC microdissection method, collected in pool and examined by a 
multiplex Taqman PCR. 
For experiment 2 the erythroblasts enriched from maternal blood by Soybean Lectin-
based method were transferred onto membrane slides and MGG stained.  
Single erythroblasts with small dense nucleus, which were resistant to FISH analysis, 
were isolated by the LPC microdissection method and every cell was examined by a 
multiplex single cell Taqman PCR which had been optimized for the analysis of single 
cells.  
Results 
1) Taqman PCR analysis of pooled erythroblasts microdissected from maternal blood 
Our in blinded way examination of 6 samples obtained from pregnant women has 
indicated that in 2 from 4 cases the fetal gender was determined by Taqman PCR analysis 
on pool of collected erythroblasts. The sensitivity and specificity of our analysis were 
50% and 100%, respectively. 
Thirty two erythroblasts were collected by PALM microdissection from membrane slides 
and analyzed by single cell Taqman PCR analysis with GAPDH–VIC probes. The 
amplification efficiency was 43.3%. On average 28 erythroblasts was microdissected 
(Table 30). 
 
Cases 
ID 
Gender Number of 
cells in the 
pool 
GAPDH SRY 
3087 male 31 positive positive 
3107 male 10 positive negative 
3697 male 20 positive negative 
3699 female 29 positive negative 
3031 male 31 positive positive 
3039 female 45 positive negative 
 
Table 30. Taqman PCR analysis of pooled erythroblasts microdissected from maternal blood 
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2) Single cell Taqman PCR analysis of erythroblasts microdissected from maternal blood 
Our in blinded way examination of 6 samples obtained from pregnant women has 
indicated that in 2 from 2 cases the fetal gender was determined by single cell Taqman 
PCR analysis with GAPDH-VIC and SRY-FAM probes. On average 14 erythroblasts 
(range from 4 to 24) were microdissected. The average amplification efficiency was 
52.0%. The sensitivity of our analysis for detection fetal gender was 100% and specificity 
100% (Table 31). But the proportion of fetal cells from all successfully amplified 
erythroblasts was in the first case (ID 3842) 33%, in the second case (ID 3843) 20%.  
 
Case ID Gender Number of 
microdissected 
cell 
Number of 
GAPDH-
VIC 
positive 
Number of 
SRY-FAM 
negative 
Tagman 
efficiency, 
% 
3841 female 20 10 0 50.00 
3842 male 16 2 1 18.75 
3843 male 24 5 1 25.00 
3868 female 4 3 0 75.00 
3885 female 6 5 0 83.33 
3886 female 20 12 0 60.00 
      
 Average    52.01% 
 
Table 31. Single cell Taqman PCR analysis of erythroblasts enriched by Lectin method from maternal 
blood and microdissected from membrane covered slides.  
 
Conclusion 
We have demonstrated that the use of membrane-coated slides for lectin enrichment for 
LPC microdissection restricts severely the use of this approach because of the very high 
level of background of those slides that influences the quality of analysis. The percentage 
of fetal erythroblasts among all those amplified successfully was on average only 25%. 
Our preliminary data have indicated that the single cell Taqman PCR analysis on 
erythroblasts microdissected by PALM technique is reliable for the detection of fetal 
origin of erythroblasts but this issue will have to be explored in an extended study. 
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Figure 30. Single cell singleplex Taqman PCR analysis on erythroblasts from cord
blood (amplification efficiency for SRY locus is 63%). 
Figure 31. Single cell multipley Taqman PCR analysis on erythroblasts from cord
blood (amplification efficiency for SRY locus is 75%).
 
90 
3. Discussion  
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3.1. The majority of erythroblasts in maternal blood are impervious to 
the analysis by FISH 
The results of our study of erythroblasts in maternal blood have indicated that only half 
of the erythroblasts could be efficiently analyzed by FISH, and that these were largely of 
maternal origin, as they had a XX genotype. Only a small fraction of the erythroblasts 
(<5%) in maternal blood could be reliably identified as being of fetal origin on the basis 
of clear FISH signals for the X and Y chromosomes. The remaining portion of this pool 
of circulating erythroblasts appeared to be refractory to FISH analysis. 
This feature was evident not only for the Y chromosome, but also for the analysis of 
chromosomes X and 18. Furthermore, this feature could not be overcome by employing 
microwave treatment, which hade previously been shown to be effective for the FISH 
analysis (Durm et al., 1997).  
Our data further indicate that this group of erythroblasts differs from those which are 
clearly of maternal origin in that they have a small dense nucleus containing fragmented 
DNA. However, we have determined that the inability to analyze these cells efficiently 
by FISH was most likely not due to the presence of fragmented DNA but rather due to a 
small dense compact nucleus.  
This result was most evident in our analysis of cord blood erythroblasts, whose nuclei 
could all be efficiently analyzed by FISH despite being TUNEL positive. In previous 
studies using single-cell PCR on individual erythroblasts isolated by micromanipulation, 
it was observed that almost 50% of the erythroblasts in the maternal circulation were of 
fetal origin (Troeger et al., 1999b). Although these cells were not selected on the basis of 
having a small dense TUNEL positive nucleus, it would appear that the erythroblasts, 
which are impervious to FISH analysis, are also of fetal origin. This hypothesis is 
supported by our ongoing studies using PCR which indicate that a number of these 
erythroblasts with small dense nuclei are indeed of fetal origin. 
Our data also provide a possible reason for this difference between putative fetal and 
maternal erythroblasts in the maternal circulation. Probably, this change in the nuclear 
phenotype may be triggered by the difference in oxygen tensions existing between the 
mother and fetus. In this regard, it is interesting to note that previous studies have shown 
that when fetal erythroblasts enter the maternal circulation, their nuclear DNA becomes 
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fragmented (Sekizawa et al., 2000), as detected by the TUNEL assay, and that this affect 
can be mimicked by exposing such cells to elevated oxygen concentrations (Kondo et al., 
2002). The investigations of Hristoskova et al. (2003) have suggested that this process of 
nuclear cleavage is associated rather with terminal differentiation and subsequent 
enucleation, than with apoptosis, as these cells do not express other characteristic 
apoptotic markers. In our current analysis we have demonstrated that 24-hour culture 
under elevated oxygen conditions leads to a significant reduction in the size of fetal 
erythroblast nuclei, and that this significantly influences the efficacy of these 
erythroblasts to be analyzed by FISH. 
As we have tested only a single 24-hour time point, it is currently unclear whether shorter 
periods of exposure also lead to similar nuclear condensation. This aspect, which remains 
to be explored, may help to explain why under certain conditions, such as immediate 
post-termination, fetal erythroblasts can be reliably detected by FISH analysis (Choolani 
et al., 2003). 
Taken together, our data suggest that a large proportion of the erythroblasts in the 
maternal circulation cannot be reliably analyzed by FISH, and that it is probable that 
many of these cells are of fetal origin. It appears also that decrease in nucleus diameter is 
induced by the higher oxygen tension present in the maternal circulation. 
Our data also hint at why fetal erythroblasts were detected with lower efficacies when 
using FACS-based procedures compared to MACS-based ones (Bianchi et al., 2002). In 
the studies using FACS, tight constraints were placed on enriching cells with well defined 
fetal erythroblast specific characteristics (expression of gamma globin), whereas in the 
studies using MACS, the cells were enriched only on the basis of CD-71 expression, and 
no attempt was made to determine whether the fetal cells being examined were indeed 
erythroblasts. It is therefore possible that in the latter instance fetal cells other than 
erythroblasts may have been examined. 
Although we have examined exclusively the well defined mature erythroblasts in this 
study, it is possible that these data may be extendable to more immature fetal 
erythroblasts, such as those expressing fetal or embryonic globin molecules. The reason 
for this is that in most instances, the detection of such fetal cells by FISH has not been 
very reliable, except in samples obtained immediately after a termination of pregnancy or 
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an invasive procedure, such as chorionic villus sampling (CVS). It is therefore possible 
that under normal conditions these early fetal erythroblasts undergo nuclear changes once 
they enter the maternal circulation similar to that which we have seen in this study. 
In summary, our data provide an explanation for the apparent lack of fetal erythroblasts 
in the maternal circulation, or the inability to detect them with high degree of sensitivity 
when using FISH for their analysis (Bianchi, 1999). This facet will have to be considered 
in future potential diagnostic approaches.  
Alternative strategies may, hence, focus on the use of primed in situ-labelling (PRINS), 
as this method relies on smaller molecules than current FISH-probes for the detection of 
fetal specific sequences, which may be able to enter the dense fetal erythroblast nuclei 
more successfully. 
 
3.2. Soybean Lectin-based enrichment 
Although the efficiency of the erythroblast recovery by MACS that we have achieved in 
this study is comparable with data from other studies, it is clear that the SBA-lectin 
method offers a better recovery. The present study also serves to indicate that numerous 
erythroblasts are being lost during the MACS procedure. In this regard, it has previously 
been calculated, that cell loss due to centrifugation can be as high as 2-4% and that the 
most significant loss (almost 10-20%) occurred during the transfer of enriched cells onto 
microscope slides by cyto-centrifugation (Oosterwijk et al., 1998a). It is also likely that 
target cells are lost during the MACS procedure, in that they may be retained by the 
column or lost during the washing steps. Hence, it is possible, that the lack of such steps 
may contribute to the overall improved recovery by the SBA-lectin method. 
Another apparent advantage of the SBA-lectin method is that the enriched cells appeared 
to have a better morphology, facilitating easier recognition and analysis, than cells which 
had been treated by the MACS protocol. This facet will have to be explored in a larger 
study. 
A major drawback of all current enrichment methods, and especially that of the SBA-
lectin method, is that the final enriched cell population is contaminated by a vast number 
of maternal cells. Although the recovery by the SBA-lectin method is greater than that 
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attained by the MACS method, the purity is significantly lower. This implies that a 
considerable effort still has to be made to locate potential fetal cells after the lectin 
enrichment procedure, which renders the analysis tedious and time consuming. Therefore 
it will be necessary to employ systems which permit the automated recognition and 
recovery of potential fetal cells, in order to obtain the optimal efficiency required for 
clinical applications. For this reason studies are ongoing which explore the use of systems 
facilitating automated recognition of rare events and their subsequent contact free 
isolation by laser pressure catapulting (Hahn et al., 2002).  
In summary, our study indicates that the lectin-based method is more efficacious than 
MACS approach for the enrichment of erythroblasts from maternal blood, and that this 
method may be a promising alternative for future investigations concerned with non-
invasive prenatal diagnosis.  
 
3.3. XYY – FISH on whole blood 
Krabchi et al. (2001) have shown 100% specificity for 12 male pregnancies in a non-
blinded manner using hypotonic treatment combined with Carnoy`s fixation. Ten of these 
pregnancies were analyzed by conventional XY-FISH and two – by XY-chromosomal 
PRINS. Although these studies yielded important information concerning the number of 
circulating fetal cells in maternal blood, the results are possibly skewed by the fact that 
they were not conducted in a blinded manner concerning the sex of the fetus. 
Using the same experimental set-up like Krabchi et al. (2001) but in a blinded manner we 
have obtained specificity 69.4% and sensitivity 52.4% in our previous study 
(Mergenthaler et al., 2005). The increase in specificity up to 89.5% in this study has been 
achieved by substituting the X-chromosomal probe with a second Y-chromosomal probe 
from a different region of the Y-chromosome (α- and III-satellite). However a slight 
reduction in sensitivity (down to 42.9%) was detected. Although this study did indicate 
that male fetal cells were present in the vast majority of pregnancies with male fetuses, 
we were anxious to improve upon the accuracy of our method. For this reason we have 
again used two similar Y chromosome-specific FISH probes (α- and III-satellite) but now 
in combination with an X chromosome-specific FISH probe (one-step two-color XYY-
FISH). The present investigation indicated that circulatory male fetal cells can now be 
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detected with 75% specificity and 91% sensitivity, which is a considerable improvement 
over our previous results. The efficacy of this approach also becomes readily apparent in 
our parallel assessment of the same samples by conventional XY-FISH, where male fetal 
cells could be detected only with 50% specificity and 60% sensitivity which is 
comparable with data in our previous study (Mergenthaler et al., 2005).  
The mathematical calculation of probability of labeling the fetal cells by XY-, YY-and 
XYY-probes combinations gives the values 0.81, 0.81 and 0.891, respectively (in the 
mathematical model we took equal FISH efficiency of 90% for X-, Y- (α-satellite) 
centromeric and Y (III-satellite) probes, as described by the manufacturer). Thus, the 
labeling of Y chromosome by two different probes (centromeric Yp11.1-q11.1 and q12 
regions) by the same color in the one-step two-color XYY-FISH has advantage in 
detecting fetal Y-chromosome over other methods of labeling mentioned above. 
Theoretically, the increase in the number of Y chromosome probes labeled by the same 
color leads to an increase in the probability of Y-chromosome detection. In our present 
study we demonstrate the results which confirm this mathematical prediction. 
Our data were also quite encouraging concerning the number of male fetal cells detected 
per 1 ml of maternal blood. The actual frequency of erythroblasts in the maternal 
circulation is difficult to assess, and it varies considerably according to the enrichment 
technique used and methods of evaluation. In an interstudy–comparison regarding fetal 
cell number the average concentration of 2 fetal cells per 1 ml of maternal blood found by 
Krabchi et al. (2001) matches approximately the concentration of 1.2 fetal cell 
equivalents per 1 ml of maternal blood found by Bianchi et al. (1997) using PCR. Our 
previous results (Mergenthaler et al., 2005) exceed these average cell numbers. In the 
present study we have enumerated from 8 to 16 and from 8 to 32 fetal cells per 1 ml of 
maternal blood by XY- and XYY FISH, respectively. It means that more male fetal cells 
were detected by the XYY-FISH approach in comparison with conventional XY-FISH. 
The reasons for differences in the values between our study and studies of other 
researchers might be due to the much broader range of gestational age of our patients, due 
to the different manner of evaluation (blinded and non-blinded), due to the procedure-
inherent factors influencing the FISH efficiency (Hromadnikova et al., 2002) and due to 
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the number of cases used for these studies which is non-sufficient for all mentioned 
above studies the statistically reliable result. 
Akin to our previous study, male fetal cells could be detected in the majority of maternal 
blood samples examined. No male fetal cells could be detected in 3/10 (30%) of XY-
FISH experiments and in 1/11 (9%) of XYY-FISH experiments of pregnancies with a 
male fetus. One of the reasons for this is that we used the amount 0.125 – 0.25 µl (1-2 
slides) of maternal whole blood that does not seem to be sufficient to guarantee the 
presence of a reliable number of fetal cells. 
Our study has revealed that the using double labeling of Y-chromosome (XY-Y-
Qbiogene protocol) results in improved fetal cells recovery and enables a reliable 
prospective non-invasive fetal sex determination.  
 
3.4. Spectral morphometric comparative analysis of erythroblasts from 
maternal and cord blood 
Spectral morphometric analysis was used in the present study for the characterization of 
erythroblasts from maternal and cord blood on the basis of spectral nuclear and 
cytoplasm features.  
In 1991, Haaf and Schmid (1991) stated that the existence of highly ordered 
organizational patterns in the cell nucleus probably could provide a structural framework 
for efficient processing of nuclear events. Therefore, in 1992, Sorensen hypothesized that 
the nuclear structure is a reflection of the metabolic state of the nucleus. In support of this 
hypothesis, many other researches suggest also that the specific nature of the 
compartmentalization could reflect the physiological state of a given cell (Popp et al., 
1990; van Dekken et al., 1990; Vourc'h et al., 1993). 
Zirbel et al. (1993) have proposed a model predicting that the surface of chromosome 
territories and a space formed between them provide a network-like three-dimensional 
nuclear compartment for gene expression, mRNA splicing, and transport, termed the 
interchromosome domain compartment.  
During erythropoesis major nuclear components, such as DNA, RNA, histone and 
nonhistone proteins, inorganic materials, water and cytoplasmic content, for example, 
haemoglobin, as well as nucleo-cytoplasmic (N/C) ratio could undergo changes. These 
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changes may be different in erythroblasts in maternal blood and in cord blood and as a 
result, this could produce different spectral patterns in these cells. 
On the basis of the present results, we assume that the circular patterns in erythroblasts 
from maternal blood and windmill patterns in erythroblasts from cord blood revealed by 
spectrally resolved imaging define a different three-dimensional compartmentalization of 
chromatin in the nucleus of these cells. 
The symmetry observed in the nuclei may be maintained by electric forces. According to 
Zirbel et al. (1993), short-range and long-range electric forces resulting from charge 
distribution effects of chromosome territories and other nuclear components may be 
involved in the maintenance of the interchromosomal domain. 
In our study we present the possibility of spectral morphometry for the disclosure of the 
distinctions of the erythroblasts. Although the MGG stained erythroblasts in maternal 
blood and in cord blood look similar, display similar properties, we have detected 
spectral distinctions between them. 
In erythroblasts from maternal blood the reference spectra No.1 of the spectral library 
dominated in comparison with that in erythroblasts from cord blood. The reference 
spectra No.1 may be associated with high degree of condensation of the nuclei in 
maternal blood, whereas in the cord blood the nuclei are less condensed. These data are 
in good correlation with results of morphometric measurements and with results of FISH.  
In erythroblasts from maternal blood the highly condensed chromatin was symmetrically 
condensed, whereas in the cord blood it shows windmill-like structure. In other study 
Rothman et al. (1997) have detected by spectral imaging the windmill-like structures of 
high symmetry in basophilic, polychromatic, and orthochromatic normoblast cells from 
bone marrow. They also have determined that apoptosis was associated with a gradual 
breakdown of the ordered arrays in the nuclei. 
The reference spectra No.4 may be associated with accumulation of haemoglobin and 
other molecules or may be due to accumulation of degraded DNA in the cytoplasm of 
erythroblasts (Hendzel et al., 1998). We suppose that in erythroblasts from maternal 
blood the nucleus is more condensed and the DNA is accumulated in cytoplasm as a 
result of apoptosis. 
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The spectral imaging morphometry has advantages over the image analysis systems now 
in use. In addition to standard morphometric parameters, spectra (400-850 nm) are 
obtained for each pixel of an image, providing more information than conventional image 
analysis.  
Today, the micromorphometry plays an increasing role in clinical diagnosis by providing 
clue derived from the shape and structure determinations of cell nuclei. Spectral imaging 
enhances the information obtained with light microscopy by providing multipixel spectra 
that otherwise are impossible to obtain from cytological specimens (Malik et al., 1996; 
Malik et al., 1997; Rothmann et al., 1997; Rothmann et al., 1998; Barshack et al., 1999; 
Greenspan et al., 2002). We propose that spectral morphometric analysis may serve as an 
additional diagnostic tool for detection of erythroblasts in maternal blood specimen. 
 
3.5. Future directions 
A long-term goal of all obstetricians and gynecologists is the development of simple, 
rapid, accurate, non-invasive tests for prenatal diagnosis. There is no doubt that fetal cells 
in maternal circulation do exist and that they can be used for the analysis of fetal 
aneuploidies and inherited Mendelian genetic disorders, but until now there exist some 
limitations for diagnostic applications. For example, the efficiency of FISH analysis on 
erythroblasts enriched from maternal blood is very low. In our study we have 
demonstrated that nuclear structure of erythroblasts is not suitable for FISH analysis. Our 
discovery that fetal erythroblasts in maternal circulation have small dense nuclei appears 
disappointing at present. However, more tests are needed to be done and a large number 
of samples are needed to be processed to confirm this and to understand more details on 
the nature and mechanisms of erythroblasts degradation in maternal blood. 
In order to use the fetal cells in clinical applicability a significant amount of work have to 
be done concerning the choice of fetal cells for analysis, selection of specific fetal 
markers, as well as development of optimal enrichment procedures which have to be 
more effective and not so labour-intensive as current ones. It will also be important to 
determine more closely at what stage of pregnancy circulatory cells can be detected 
reliably, as in our current study we have examined a broad spectrum of gestational ages. 
Next important moment is to determine the frequency of fetal cells at early stages of 
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pregnancy at those stages when they may be useful as the basis for a non-invasive 
prenatal diagnosis during the first trimester. Furthermore, the fetal source (placental or 
haemopoietic) of fetal cells is also of considerable interest, as this may lead to the 
development of new tools permitting the efficacious isolation of fetal cells from maternal 
blood samples. 
Therefore, the expansion of the molecular genetic diagnostic options, for example the 
primed in situ hybridisation (PRINS) analysis, needs to be optimized for use with fetal 
cells from maternal blood, or new techniques are to be developed. 
The rapid PCR analysis of single fetal cells could be improved by the adaptation of laser 
micromanipulation protocols and by optimization of amplification procedures, for 
example applying the whole genome amplification procedures.  
Finally, for clinical applicability, once all aspects of the non-invasive prenatal diagnostic 
technique have been optimized, these can be automated. The automated scanning 
technique (Metafer P; MetaSystems; Germany) can be combined with laser 
microdissection and pressure catapulting (LMPC; Germany), allowing automatic 
detection, isolation and collection of single fetal cells from maternal blood. 
Such possibility has the promise of being a big step forward in developing protocols for 
non-invasive prenatal diagnosis.  
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4. Materials and Methods  
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Samples 
The study was approved by the Cantonal Review Board of Basel and written informed 
consent was obtained in all instances. Cord blood samples were collected with EDTA 
immediately after birth from women with normal gestation who delivered normal infants. 
Maternal blood samples were collected with EDTA at 10 to 40 gestational weeks from 
women with normal singleton pregnancies. All samples were processed within 6 hours 
after blood sampling.  
 
CD 71 Enrichment 
We performed the CD 71 enrichment according to the protocol which had been 
established in our laboratory (Troeger et al., 1999a). In brief, the mononucleated cells 
were separated with a single density gradient using Histopaque 1083 (Sigma, Fluka 
Chemie GmbH, Buchs, Switzerland). After washing, for the positive selection, cells were 
incubated with anti-CD71 microbeads (Miltenyi Biotec GmbH, Bergisch Gladbach 
Germany) and separated using miniMACS separation columns following the 
manufacturer’s instructions (Miltenyi Biotec GmbH, Bergisch Gladbach Germany). 
 
Slide Preparation and May-Grünwald-Giemsa (MGG) staining 
The positively enriched cell fraction was transferred onto Superfrost PLUS glass slides 
(Mentzel-Gläser, Germany) by cytocenrifugation (Shandon, Frankfurt, Germany) in 
amount of 105 cells per one slide. The slides were stained differentially by May-Grünwald-
Giemsa (MGG) (Sigma, St. Louis, MO, U.S.A.). 
 
SBA galactose-specific lectin enrichment 
The lectin enrichment method was performed as described previously (Kitagawa et al., 
2002), except that a concentration of 100 µg/ml soybean agglutinin (Vector, Geneva, 
Switzerland) was used. In brief, for SBA enrichment the blood (7-8.5 ml) was diluted 
with phosphate-buffered saline (PBS) and the mixture was layered over 3 ml Histopaque 
1077 (Sigma, Fluka Chemie GmbH, Buchs, Switzerland) that was adjusted to density 
1.095 g/ml by adding sodium diatrizoate (Sigma, Fluka Chemie GmbH, Buchs, 
Switzerland). After centrifugation at 400g for 30 min at RT without break, the 
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mononuclear cells were collected and washed three times with PBS by centrifuging once 
at 750g for 10 min, and twice at 400g for 5 min at RT. The pellet was resuspended in 3 
ml of panning solution (RPMI 1640 (Invitrogen AG, Basel, Switzerland) +5% FCS). The 
mixture of cells for negative enrichment was placed on dish coated with 5% inactivated 
FCS in panning solution and incubated at 37°C for 30 min. The attachment of cells was 
controlled under the microscope. After incubation, the suspension containing unattached 
cells was collected after several washes of the dish and washed by centrifugation at 400g 
for 5 min at 20°C. The suspension was diluted with SBA solution (100 µg/ml soybean 
agglutinin (SBA) (Vector, Geneva, Switzerland) in PBS-buffer) to a concentration of 
2x106 cells/ml. 1 ml of this suspension was put in each chamber of the slides (Nalge 
Nunc International, Millian, Geneva, Switzerland) coated with PV-MeA (Poly-[N-p-
vinylbenzyl-O-a-D-galactopyramnosyl-(1-6)-D-gluconamide]) (NeTech, Kanagawa, 
Japan) at a concentration of 200 µg/ml and incubated at 15°C for 30 min while shaking 
the slides gently every 10 min.After incubation, the suspension containing unattached 
cells was decanted from the chamber slide, and the attached cells were washed with PBS 
buffer. 2 ml hypotonic solution (FCS/Water, 3:2) were added to every chamber and 
chamber slides were centrifuged at 17g for 5 min at 20°C. After centrifugation the 
medium was decanted from chamber and chambers were separated from the slides. The 
slides were centrifuged vertically at 68g for 10 min at 20°C and immediately dried with 
air for 30 min. The slides were incubated in a humid camera overnight at RT and then 
fixed in 95% mathanol for 20 seconds, in 50% methanol in 1/15 M phosphate-buffer for 
20 seconds at RT and in 2% methanol in 1/15 M phosphate-buffer for 3 min at RT, 
washed briefly in Millipore water. Cells immobilized on the slides were MGG stained.  
 
Light Microscopic Evaluation 
Using a conventional microscope (Axioplan 2 imaging microscope system, Carl Zeiss, 
Zürich, Switzerland), every slide from cord blood and maternal blood after MGG staining 
was analyzed for cells content according to next criteria: a) optimal density of cells; b) 
undestroyed cellular morphology; c) good MGG staining. The cells with low nucleus-to-
cytoplasm ratio, dense and small nucleus, and orthochromatic, non-granular cytoplasm 
were considered as erythroblasts. 
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For maternal blood slides total number of erythroblasts on the slide was accounted and 
position of every erythroblast was electronically marked using a digital automated location 
finder software (Axiovision 3.1, Carl Zeiss, Zürich, Switzerland) and MGG image for 
every cell was captured, using CDC camera (AxioCam, Carl Zeiss, Zürich, Switzerland). 
 
Carnoy`s fixation on whole blood. 
One milliliter of whole maternal peripheral EDTA-blood was processed within 6 hours 
after sampling. After washing with 8 ml RPMI 1640 (Invitrogen, Basel, Switzerland) by 
centrifugation at 1000 rpm for 8 min at RT the samples were incubated with 10 ml of pre-
warmed 0.4% KCL for 20 minutes at 37°C, fixed several times with freshly prepared pre-
cooled Carnoy`s fixative (methanol: glacial acetic acid, 3:1) and centrifuged at 1000 rpm 
for 8 min at RT and incubated overnight at –20°C. Then the cells were washed in 1% 
BSA/PBS, resuspended by pipetting. The slides were prepared by cytocentrifugation (8 
slides per case). 
Pretreatment of slides involved 0,005% pepsin digestion for 10 min and fixation for 10 min 
in 1% formaldehyde. 
 
Immunocytochemistry (ICC) 
The slides were fixed in 100% methanol for 10 min, 100% acetone for 10 min and in 10% 
formaldehyde for 10 min. Then they were incubated with 20% goat serum (Sigma) diluted 
in 1% BSA-PBS for 45 min followed by incubation with monoclonal mouse anti-human 
Glycophorin A (GPA) antibodies (1:2000 diluted in PBS) (Dako A/S, Denmark) for 10 
min. Subsequent incubations were performed with biotinylated anti-mouse 
immunoglobulins (Dako A/S, Denmark), and with streptavidin (Dako A/S, Denmark), both 
were incubated for 10 min. Then the slides were stained by Vector blue alkaline 
phosphatase substrate (Kit III, Vector Laboratories, Burlingame, USA) for 15 min. 
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Fluorescence In Situ Hybridization (FISH) 
 
Pretreatments: 
Microwave – activated pretreatment: The slides were mounted on a small glass filled with 
30 ml PBS and placed in the center of circling plate of commercially available microwave 
oven (Bosch, Germany). Activation was performed at 700 W for 40 sec. 
Pepsin treatment: With examined different concentration, temperature and duration of 
time, the following optimal conditions were determined: 0.005% pepsin/water, for 30 sec 
at 37ºC (Table 2). 
Proteinase K treatment: The concentrations 0.5 mg/ml and 1 mg/ml and time of treatment 
from 1 min to 30 min were examined. 
HCL treatment: The concentrations 0.1 M and 0.2 M and time of treatment from 30 sec 
min to 20 min were examined. 
 
Choice of Probes: 
For the comparison of the efficiency of different direct labeled fluorescence DNA probes 
the MGG-stained slides were hybridized in different FISH-experiments with probes from 
Vysis and Qbiogene companies (Table 4; Figure5). 
Vysis: two–color chromosome X/Y cocktail probe (CEP X spectrum green, alpha satellite, 
region centromeric Xp11.1-q11.1; CEP Y spectrum orange, alpha satellite, region 
centromeric Yp11.1-q11.1).  
Qbiogene: two–color chromosome X/Y cocktail probe (X centromeric (DXZ1), alpha 
satellite, fluorescein and Y centromeric (DYZ3), alpha satellite, rhodamine).  
Besides, we examined different combinations of Qbiogene probes: 
Mixture of chromosome X centromeric (DXZ1), alpha satellite, rhodamine and 
chromosome 18 satellite probe, fluorescein, in proportion 1:1; 
Mixture (and separately) of chromosome Y centromeric (DYZ3), alpha satellite probe, 
fluorescein and chromosome Ygh, classical satellite probe, rhodamine, in proportion 1:1; 
Mixture of two-color chromosome X/Y cocktail probe (X centromeric fluorescein, Y 
centromeric rhodamine) and Ygh classical satellite probe, rhodamine; in proportion 1:1. 
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Hybridisation procedure: 
The FISH procedure was performed according to the manufacturer’s instructions with 
slight modifications. 
Vysis probes hybridisation 
For each slide, hybridization reaction was prepared by mixing 7 µl of CEP hybridization 
buffer (for repetitive sequence DNA probes) with 1 µl of probe and 2 µl of deionized water 
in Eppendorf  tube for total 10 µl of hybridisation solution. The slides were dehydrated 
with 70%, 85%, and 96% ethanol, 2 min each, and then allowed to air dry. 
After air-drying the slides, 10 µl of probe mixture were applied to slide and covered by 
coverslips. The slides were placed in HYBrite hot plate (Vysis). The probes and DNA were 
denatured at 72ºC for 2 min and then hybridized 37ºC for 16 hours.  
The post-hybridization washes were made by transferring the slides to a bath of 0,4xSSC 
0.3% Nonidet P-40 (NP-40) for 2 min at 72ºC and then were washed briefly in 2xSSC 
0.1% NP-40 for 30 sec at RT. Then the slides were kept in the dark until air drying. Then 
for every slide DAPI/Antifade was applied and the slides were covered with glass 
coverslips. 
Qbiogene hybridisation 
The procedure was performed according to manufacturer`s protocol with slight 
modifications. The pretreatment of slides was made in 2XSSC, pH 7.0/0.5% Igepal (NP-
40) at 37 C for 10 minutes. Then the slides were dehydrated with 70%, 80% and 95% 
Ethanol for 2 minutes each and then allowed to air dry. The probes were pre-warmed at RT 
and were applied in amounts of 10 µl to slides and covered by coverslips. The sample and 
probe were co-denatured in HYBrite hot plate (Vysis) at 80ºC for 2 min. The hybridization 
was at 37ºC overnight. The post-hybridization washing was performed in 
0.5XSSC/0.1%SDS for 5 min at 37ºC without agitation. Then DAPI/Antifade was applied 
and the slides were covered with applied glass coverslips. 
 
Fluorescence microscopy analysis 
The FISH efficiencies for cord blood samples were determined by scoring the 100 cells 
from erythroblast population. All the erythroblasts that showed two clearly distinctive 
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hybridization signals were registered as correctly hybridized. Those erythroblasts that were 
recorded as XO, YO or OO were considered as a failure of the hybridization. All the 
signals observed with the triple band pass filter were confirmed with fluorochrome specific 
monochromatic filters (Carl Zeiss, Zürich, Switzerland). 
After FISH the slides from maternal blood were rechecked for every recorded position of 
erythroblasts. The FISH result was evaluated according to the criteria, described above. 
Then Y signal screening for all slides was performed. The cells showed the representative 
signals were captured using CCD camera. 
 
Morphometric analysis 
The measurements were made on MGG images using the Zeiss Axiovision 3.1 
measurement software (Carl Zeiss, Zürich, Switzerland). Every nucleus was measured 
along the longest axis and along shortest axis. The average of such two measurements for 
every nucleus was taken as “diameter” for further analysis. For every nucleus, the 
circumference of the nucleus was also measured. The N/C ratio was calculated from 
measurements of area of the nucleus and the cell 
 
Terminal dUTP Nuclear End Labeling (TUNEL) 
TUNEL staining was performed using a commercially available in situ cell death 
detection kit (Roche Molecular Biochemicals) according to the manufacturer’s 
instructions. In brief, the cells were cytospinned on a glass slide, stained by the May-
Grünwald-Gimsa (MGG) method and fixed with 4% paraformaldehyde/PBS solution at 
RT for 30 minutes. After washing with PBS the slides were permeabilized with 0.1% 
Triton X-100/0.1% sodium citrate for 5 minutes on ice and washed twice with PBS. Cells 
were then incubated with 50µl TUNEL mixture for 1h at 37º C in a humidified chamber. 
After washing twice, the slides were incubated with 50 µl Converter-AP for 30 minutes at 
RT, followed by incubation with the DAKO Fuchsin Substrate-Chromogen (DAKO) for 
10 minutes at room temperature. As positive and negative controls, the samples were 
incubated with DNAase I and with label solution devoid of terminal deoxynucleotidyl 
transferase (TdT), respectively. The TUNEL staining result was checked by a light 
microscope (Zeiss Axioskop, Germany) for every recorded erythroblast. 
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Culture at different oxygen concentrations 
Eight hundred microliters of cord blood were added immediately after delivery to 10 ml 
of PB-MaxTM (Gibco, Invitrogen AG, Basel, Switzerland) with 100 µl of 
Antibiotic/antimycotic solution.  
Cells were then incubated for 24 hours under two different oxygen concentrations: 3% O2 
and 20% O2 at 37oC. To equilibrate the oxygen concentration in the medium, the medium 
was preincubated in the incubators for 2 hours at least. After 24 h of incubation the cells 
were transferred from the flask to 15 ml tubes and centrifuged at 1600 rpm x 10 min. The 
smears were made from fresh cord blood and from the same cases after cultivation. The 
slides were stained by MGG. The erythroblasts were then identified morphologically and 
counted. The relative number of erythroblasts was calculated as the number of 
erythroblasts per 100 nucleated cells. 
 
Statistics 
We used the Wilcoxon sign-rank test to analyze differences between the results for 
culture at 3% and 20% oxygen. P value (Asymp. Sig. (2-tailed)) less than 0.05 was 
considered as indicating the statistical significance. 
To check the significance of difference in size between nuclei with XX FISH signals and 
without any signal and to analyze differences in distribution of spectra No.1 and spectra 
No.4 between cord blood erythroblast and the ones from maternal blood we used the 
Student’s t-Test (2-tailed) assuming unequal variances, with a p value less than 0.05 
indicating statistical significance. To check the significance of difference in size between 
nuclei with XX FISH signals and without any signal we applied ANOVA test also. 
Laser Microdissection and Pressure Catapulting (LMPC) technology 
MGG slides with and without special membrane from maternal blood cases which have 
demonstrated many erythroblasts and no FISH signals on them were subjected to laser 
microdissection and Pressure Catapulting (LMPC) (P.A.L.M. Microlaser Technologies, 
Bernried, Germany). 
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Single cell or pool of cells were collected in 15 µl of pro K solution/SDS (400ng/1µl) 
from every such case and frozen –20˚C overnight. After unfreezing the cells were 
centrifuged at 16000 rpm for 5 min and subjected to proteinase K (pro K) treatment at 
56˚C for 8 hours with following inactivation pro K at 96˚C during 10 min. Thereafter the 
cells were centrifuged at 16000 rpm for 5 min and were tested by Real-Time PCR. 
 
Real-Time Polymerase Chain Reaction (PCR) 
Real-Time PCR specific for the SRY (sex-determining region Y-chromosome) and 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) genes or for 18 chromosome and 
21 chromosome was carried out using a Perkin Elmer Applied Biosystems 7000 
Sequence Detector (TaqMan, Applied Biosystems, Boston, USA). In brief, the 50 µl of 
amplification reaction mixture consisted of 300 nM of each primer and MGB labeled 
TaqMan probe, 25 µl TaqMan Universal PCR Master Mix (3.5 mM magnesium chloride, 
100 mM dNTPs, 0.025 U AmpliTag Gold and 0.01 U Amp Erase (Perkin-Elmer, USA)). 
The following primers were used: 
GAPDH forward primer 5`CCCCACACACATGCACTTACC3` 
GAPDH reverse primer 5`CCTAGTCCCAGGCCTTTGATT3` 
GAPDH MGB Probe 5`AAAGAGCTAGGAAGGACAGGCAACTTGGC3` 
SRY forward primer 5`TCCTCAAAAGAAACCGTGCAT3` 
SRY reverse primer 5`AGATTAATGGTTGCTAAGGACTGGAT3` 
SRY MGB probe 5`CACCAGCAGTAACTCCCCACAACCTCTTT3` 
18 chromosome forward primer 5`TGACAACCAAACGTGTGTTCTG3` 
18 chromosome reverse primer 5`AGCAGCGACTTCTTTACCTTGATAA3` 
18 chromosome MGB probe 5`GGTGTTTTGGAGGAGTT3` 
21 chromosome forward primer 5`CCCAGGAAGGAAGTCTGTACCC3` 
21 chromosome reverse primer 5`CCCTTGCTCATTGCGCTG3` 
21 chromosome MGB probe 5`CTGGCTGAGCCATC3` 
The following conditions were used for the PCR amplification: an initial incubation at 
50ºC for 2 minutes and at 95ºC for 10 minutes, followed by 45 cycles of 60ºC for 1 
minute and 95ºC for 15 seconds. In each real-time PCR analysis positive and negative 
controls were included.  
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Spectral Imaging 
Fourier Transform Multipixel Spectrometry System for Microscopy. Spectral Imaging 
was performed using the SpectraCube SD-200 (Applied Spectral Imaging; Migdal 
HaEmek, Israel), (Malik et al., 1996), attached to a microscope (Axioscope 2 plus). 
Multipixel spectra were obtained from each cell in the range from 450 to 800 nm. A 
detailed description of the optical system is described by Malik et al., (1996) and 
Rothmann et al., (1997). 
Library. The different spectra from normal erythroblast cells were analyzed. Five 
distinctive spectra: three from nuclei and two from cytoplasm, were collected into 
spectral library and a distinct pseudo color was assigned to each one of them. Reference 
spectrum No. 1 sampled from the condensed nuclei region was assigned red; reference 
spectrum No. 2 from the less condensed nuclei region, blue-violet; reference spectrum 
No. 3 from minimally condensed chromatin on the rim of the nuclei region, pink. 
Reference spectra No. 4 and No. 5 representing two distinct cytoplasm domains, were 
assigned green and blue, respectively.  
Classification Analysis. To match each pixel in the analyzed image to the reference 
spectrum from library, so that spectral similarities were apparent, the classification 
algorithms were used. The criterion for this matching is minimal square error (MSE) 
mathematical function. The minimal square error algorithm measures the difference 
between the spectrum of each pixel composing an image and that of each reference 
spectrum. In such way, each pixel in the input image was identified with the most similar 
spectrum of the library; then, each pixel was displayed in an artificial color that 
represents a reference spectrum from library. The reconstructed image composed of 
artificial colors, reveals the degree of similarity between the library spectra and spectra of 
the image.  
Standardization and normalization. In order to overcome differences in slides that 
resulted from the fact that the specimens were taken from different patients and were 
stained on distinct days and by a different batch of stain, the standard fixation and 
staining protocols were used. To eliminate the influence of light conditions during 
spectral capturing the same setup for microscopy was used. Variation in spectra may also 
result from differences in intensity. In order to neutralize the effect of intensity variations, 
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the classification was performed using normalized spectra and library. Normalization 
steps at classification were needed in order to treat uniformly the individual samples and 
to preserve a comparison consistent with the prelabeled spectral library. 
Computational morphometric analysis. To provide objective quantitative data for cell 
characterization the region-of–interest being assessed was extracted from the pseudo-
colored image and the area of this region in pixel was measured, then the percentage of 
area was calculated. 
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